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SUMMARY 
Over the past decade, mass spectrometry has undergone tremendous technological 
improvements allowing for its application to proteins, peptides, carbohydrates, DNA, 
drugs, and many other molecules relevant to material chemistry and chemical biology. Due 
to ionization methods such as electrospray ionization and matrix-assisted laser desorption, 
mass spectrometry has become an irreplaceable tool in molecular and life sciences. 
In this treatise, a general history with the milestones of developments in mass spectrometry 
and their inventors is first presented. In the second part, the basics of mass spectrometry – 
ionization source, analyzer, and their combination with chromatographic methods – are 
shortly discussed. In the third part, analytical methods that were developed in our 
department and the context of the research projects are described and an outlook for future 
research is given in chapter 4. Finally, four selected applications in different research 
domains were chosen to show the versatility of analytics based on mass spectrometry 
(Chap. 5). 
Structure elucidation of natural products will be exemplified with the characterization of 
polyamine derivatives found in spider venoms (Chap. 5.1). The analysis of such samples is 
a challenge, because structure elucidation of new natural products is performed directly 
from a complex mixture of sometimes more than thirty similar compounds having 
frequently same molecular weights. 
In order to obtain confident interpretations, fundamental knowledge of molecular 
fragmentation reactions occurring in tandem mass spectrometry was necessary. To identify 
the origin of unexpected fragment ions, the ESI-MS/MS spectra of three synthetic 15N-
labeled polyamine derivatives were recorded on a triple quadrupole mass spectrometer 
(Chap. 5.2). The detailed knowledge of fragmentation mechanisms is essential, particularly 
when co-eluting isomeric compounds within complex mixtures such as spider venom are 
investigated.  
  
vi 
Quantification of taurolidine in human blood plasma and whole blood will illustrate the 
application of mass spectrometry in pharmacology. Recently, this drug was found to exert 
an anti-neoplastic effect that could be applied to the treatment of glioblastoma. A new 
quantification method based on HPLC-ESI-MS/MS in the “multiple reaction monitoring” 
mode that allows pharmacokinetic studies was developed (Chap. 5.3). During repetitive 
infusions in patients, we could show that the calculated serum concentrations of taurolidine 
strongly increased after the start of each infusion and continued to increase until the end of 
the infusion, followed by a rapid decline. These results indicate that a repetitive infusion of 
taurolidine is the therapeutically adequate mode of administration for the indication of 
glioblastoma multiforme. 
Finally, an example concerning the profiling – determination of structure and relative 
amounts – of glycosylated flavonol derivatives in Arabidopsis plants is given (Chap. 5.4). 
These experiments allowed the study of the function of these secondary metabolites in 
order to understand plant growth and development. We could demonstrate that subtle 
changes in the composition of flavonol glycosides can have a tremendous impact on plant 
development through auxin-induced and auxin-dependent processes. 
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1. General History 1 
I. GENERAL HISTORY AND DEVELOPMENTS 
The history of mass spectrometry begins already at the end of the 19th century in the 
Cavendish Laboratories of the University of Cambridge, England. Joseph J. Thomson 
discovered that electrical discharges in gases produced ions and these rays of ions would 
adopt different parabolic trajectories according to their mass when passed through 
electromagnetic fields. 
 
Figure 1.1. J.J. Thomson 
 
The apparatus he used consisted of a highly evacuated glass tube, fitted with electrodes 
(figure 1.2). Electrons were produced by electrical heating of a tungsten filament (C). 
Electrons were accelerated and force to form a beam by passing through discs A and B. 
Finally, they were passed through electric and magnetic fields where they were deviated 
and finally detected on a zinc sulfide screen (Thomson 1913; Dahl 1997). 
  Recent Applications of Mass Spectrometry 2 
 
Figure 1.2. System used by J.J. Thomson for determination of the m/z ratio of electrons 
These experiments allowed the determination of the mass-to-charge ratio (m/z) of 
electrons, the first charged particles that could be measured. J.J. Thomson was awarded for 
his pioneer works with the Physic Nobel Prize in 1906. A few years later, Thomson was 
able to determine the m/z values of the first atoms, the 20Ne and 22Ne isotopes, as well as 
those of the ionized O2, N2, CO, CO2, and COCl2 molecules.  
It was Thomson's student Francis William Aston who designed several subsequent mass 
spectrographs in which ions were dispersed by mass and focused by velocity. The use of 
electromagnetic focusing led to improvements in mass resolving power, and the 
subsequent discovery of not less than 212 of the 287 naturally occurring isotopes. It was 
Aston’s research that gave a proof for the fact that most natural occurring elements are 
composed of several natural isotopes. The characterization of the elements chlorine with 
isotope of masses 35 and 37, bromine with mass 79 and 81, and krypton with mass 78, 80, 
82, 83, 84, and 86 got him rewarded with the Nobel in Chemistry in 1922 (Aston 1919).  
 
Figure 1.3. F.W. Aston 
1. General History 3 
The development of modern sector field mass spectrometers, characterized with an 
extended mass range, was achieved 1917 by Arthur J. Dempster at the university of 
Chicago who developed a magnetic analyzer that focused ions formed by electron impact 
(EI) onto an electrical collector (Dempster 1917). EI-MS allowed physicists to identify 
compounds by the mass of elements that constitute molecules, and to determine the 
isotopic composition of these elements. Dempster’s mass spectrometer was over 100 times 
more accurate than previous versions (e.g. from Aston) and their design is still used to this 
day. Dempster’s research led in 1935 to his discovery of the radioactive uranium isotope 
235U. 
In the 1930’s started at the University of California, Berkeley, the carrier of an outstanding 
personality, Ernest O. Lawrence. He is best known for his invention, utilization, and 
improvement of an ion storage device, the cyclotron (Lawrence 1934). 
 
Figure 1.4. Ernest O. Lawrence 
Through the construction of machines with increasing size, Lawrence was able to provide 
the crucial equipment needed for experiments in high-energy physics. Around the 
cyclotron, Lawrence built up his Radiation Laboratory, which would become one of the 
foremost laboratories for physics research. In 1939, Lawrence was awarded with the Nobel 
Prize in Physics for his work on the cyclotron and its application. State-of-the-art, Fourier-
transform ion cyclotron resonance mass analyzers, based on Lawrence’s ion storage 
principle, represent the highest performance in terms of resolution, accuracy, and 
sensitivity. 
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Figure 1.5. Diagram of cyclotron operation from Lawrence’s 1934 patent 
The early 1940s saw the rise of synthetic organic chemistry’s demand for instruments able 
to characterize organic molecules. For this purpose, Joseph Mattauch and his student 
Richard Herzog, as well as Kenneth Bainbridge, Alfred Nier, and others focused their 
efforts on the improvement of Dempster’s mass analyzer. They developed double-focusing 
mass spectrometers combined with the incorporation of the latest vacuum technologies and 
electronics of the time, which led to the first commercial mass spectrometers (Mattauch et 
al. 1934; Johnson et al. 1953). 
During the 1940’s, William Stephens invented the time-of-flight (TOF) mass analyzer. 
Ions are separated based on differences in their velocities as they are accelerated down a 
linear flight tube (Stephens 1946). This concept was much cheaper and simpler than sector 
field instruments. Furthermore, TOF apparatuses have principally an unlimited mass range 
and excellent sensitivity. The relevance of Stephens’s idea came out only in the nineties 
when the matrix-assisted laser desorption ionization source for the characterization of 
macromolecules was developed.  
Quadrupole mass spectrometers were developed by Wolfgang Paul of the University of 
Bonn emerged in the 1950s. Therein separation of ions is reached by applying quadrupolar 
electric fields comprising radiofrequency and direct-current components. At that time, the 
challenge was the coupling of mass spectrometers to gas chromatographs in order to 
analyze mixtures (Paul et al. 1953). Later, Paul and Hans G. Dehmelt from the University 
of Washington created also the quadrupole ion trap. Both were awarded in 1989 with the 
Nobel Prize in Physics for their work on ion trapping. Quadrupoles are the most 
widespread mass analyzers nowadays, mainly in combination with gas and liquid 
chromatographic devices. 
1. General History 5 
   
Figure 1.6. Wolfgang Paul and Hans G. Dehmelt 
The field of mass spectrometric applications was importantly extended in 1956 from 
simple atom identification in molecules to the characterization of organic compounds. 
Thanks to Sir John H. Beynon and his development of fragmentation rules in EI-MS, the 
structure of organic molecules got amenable (Beynon 1956). At the same time, Fred 
McLafferty proposed a hydrogen transfer reaction that will come to be known as the 
McLafferty rearrangement (McLafferty 1956; McLafferty 1959).  
By the 1960s, mass spectrometry had become an established technique for the 
characterization of organic compounds. This breakthrough was favored by the introduction 
of the chemical ionization (CI) source invented by Munson and Field in 1966 (Munson et 
al. 1966). Nonetheless, new ion sources were demanded, because EI-MS led often to many 
fragment ions or decomposition of thermally labile compounds. In such cases, molecular 
ions (M•+) could not be detected and the molecular weight of the compounds remained 
unknown. 
Chemical ionization is based on ionization through proton transfer reactions. Small and 
polar molecules as e.g. α-D-glucose, could now be transfer to the gas phase, and ionized to 
quasi-molecular ions (e.g. [M+H]+ or [M–H]–) without dissociation reactions. 
Other so-called "soft ionization" methods emerged a few years later including field 
desorption, secondary ionization MS (or SIMS), plasma desorption, and laser desorption 
MS (Gross 2004). 
Until now, only fragment ion spectra obtained from EI mass spectra of pure samples could 
be used for structure elucidation. The analysis of crude mixture components required the 
  Recent Applications of Mass Spectrometry 6 
development of a new technology, tandem mass spectrometry (MS/MS). This type of 
instruments is using two stages of mass analysis, and is based on collision-induced 
dissociation procedures. Its relevance is also closely related to the development of soft 
ionization techniques and that lack of structure information contained in such mass spectra 
(Yost et al. 1978). 
In 1974, Alan G. Marschall and Melvin B. Comisarov developed a Fourier-transform ion 
cyclotron mass spectrometer (FT-ICR MS) on the basis of E. Lawrence’s work 
(Comisarow et al. 1974). A major advantage of FT-ICR MS is that it allows many ions to 
be detected simultaneously in a non-destructive way. These mass spectrometers also 
achieve the highest mass resolution and accuracy, allowing the study of chemical reactivity 
in the gas phase as well as ion fragmentations. 
Major technical developments were not only related to the design of new mass analyzers. 
Also innovative ionization methods allowed the extension to new application domains. A 
important effort was given to develop a method for the direct transition of ions from a 
solution to the gas phase. In 1975, E. C. Horning came initially to the idea of using heat for 
evaporation of the solvent and a corona discharge for the ionization of the molecules 
(Carroll et al. 1975). The atmospheric pressure chemical ionization (APCI) was born.  
Ionization techniques capable of efficiently ionizing biological molecules were developed 
in the 1980’s. First, Michael Barber invented the fast atom bombardment (FAB) technique, 
which uses a source of neutral heavy atoms to ionize compounds from the surface of a 
liquid matrix (Barber et al. 1981). Some years later, John B. Fenn and colleagues at Yale 
University refined an electrospray ion source originally reported by Malcolm Dole of 
Northwestern University almost two decades earlier (Dole et al. 1968). The first 
experiments dealt with the formation of a molecular beam from a small supersonic free jet 
that contained a variety of ionic species (Yamashita et al. 1984; Yamashita et al. 1984). 
Later, ions of biological macromolecules were produced in the gas phase (Fenn et al. 
1989), a development that was rewarded in 2002 with the Nobel Prize in Chemistry. 
John Fenn shared his award with Koichi Tanaka who was able to vaporize and ionize 
macromolecules such as proteins by laser irradiation. The problem of the ionization 
method is that the direct irradiation of an intense laser pulse on a macromolecule causes 
cleavage of the analyte into tiny fragments and the loss of its structure. In 1987, Tanaka 
found that by using a mixture of ultra fine metal powder in glycerol as a matrix, an analyte 
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could be ionized without dissociation (Tanaka et al. 1987). This technique became known 
as soft laser desorption (SLD). 
   
Figure 1.7. John B. Fenn and Koichi Tanaka 
Tanaka’s part of the Nobel Prize raised polemics in the scientific community because the 
contributions of two German scientists, Franz Hillenkamp and Michael Karas were 
important enough for being also included as prizewinners. In their technique, first reported 
in 1985, a laser desorbs molecules from a solid surface covered with a matrix of crystalline 
organic compound of low molecular weight (Karas et al. 1988). This procedure increases 
significantly the sensitivity and is called matrix-assisted laser desorption ionization 
(MALDI). Furthermore, Tanaka’s SLD is not used currently for biomolecules analysis, 
meanwhile MALDI is widely used in mass spectrometric research laboratories. Proteins, 
oligonucleotides, polymers, polyaromatic hydrocarbons, oligosaccharides, etc. are 
characterized with this method. However, while MALDI was developed prior to SLD, it 
was not used to ionize proteins until after Tanaka's report.  
Mass spectrometry’s characteristics have it to an outstanding position among analytical 
methods. In particular, the tremendous development of ESI and MALDI in the last fifteen 
years enabled to introduce biological molecules exceeding 1 million Daltons into mass 
spectrometers as stable gas-phase ions. The impact of the soft ionization techniques as 
irreplaceable tools in the biological sciences can be illustrated by the increase of the 
number of publications in the last years. From the over 15’000 papers related to mass 
spectrometry in 2005, more than 40% are dealing with ESI or with MALDI.  
  Recent Applications of Mass Spectrometry 8 
 
Figure 1.8. Number of articles including the words "electrospray" and "matrix assisted laser 
desorption" in the title, abstracts, or key words published each year obtained from the SciFinder 
database. 
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II. SURVEY OF THE VARIOUS METHODS 
2.1. Basics 
The importance of mass spectrometry lies above the simple determination of the molecular 
weights of organic molecules. Information related to structure or quantities of traces of 
compounds within complex samples can also be obtained by mass spectrometric methods. 
For successful analyses, several aspects, which are connected one to another, have to be 
considered: objectives of the investigation, fundamentals (physics), technical realization, 
and mass spectral interpretation. 
 
Figure 2.1. Interactions needed for a successful investigation using mass spectrometry.  
Adapted from (Gross 2004). 
MS
Application
- MW determination
- identification
- quantification
Fundamentals
- ionization processes
- internal energy
- time scale of events
- isotopic distribution
- exact mass
Technical realization
- sample introduction
- ionization methods
- type of mass analyzer
- combination of mass analyzers
- mode of operation
- coupling of separation devices
Interpretation of MS data
- characteristic ions
- (quasi)-molecular ions
- fragmentation pathways
- rules
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The basic method to carry out an analysis is common across all mass spectrometers. First, 
an organic compound or a metal complex is introduced through a sample inlet into the 
mass spectrometer. Once inside the instrument, the sample molecules are converted into 
ions in the ionization source, before being electrostatically accelerated into the mass 
analyzer, where they are separated according to their mass-to-charge (m/z) ratio. The ions 
collide with the detector and the resulting impact energies are converted into electrical 
signals. These signals are transmitted to a computer and converted into m/z and intensities 
(Koppenaal et al. 2005). The separation of the ions and their detection occur mandatorily 
in a high vacuum region, because collisions between ions and neutral molecules or atoms 
have to be avoided. 
 
Figure 2.2. Basic components of a typical mass spectrometer. *FT-ICR and Orbitrap do not use a 
standard destructive detector. 
 
For many years, only samples containing pure compounds delivered useful data. Because 
samples are often mixtures and to gain efficiency and sensitivity, hyphenated methods 
based on gas chromatography (GC), high performance liquid chromatography (HPLC), 
and capillary electrophoresis (CE) on-line coupled to mass spectrometers were developed. 
In the next three chapters, the most important ionization methods, mass analyzers and 
chromatographic systems are briefly presented. 
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2.2. Ion Sources 
Independent of the method, samples can only be investigated by mass spectrometry when 
two conditions are fulfilled: the molecules have to be in the gas phase and charged. To that 
end, several techniques based on three main physical processes – evaporation, desorption 
and spraying – were developed. 
 
2.2.1. Ionization Following Evaporation 
Electron-impact (EI). Molecules in the gas phase are bombarded with a beam of electrons 
that carry 70eV energy in a "near-miss" trajectory. This leads to interaction with electrons 
of the molecules, and one of them is ejected. During the collision, the molecule absorbs 
part of the kinetic energy (10-12 eV in average) and fragment ions are formed.  
M + e-70eV ––––––> M•+ + e-60eV + e-thermal 
In organic molecules, lone-pairs electrons are most easily ionized, followed by π- and σ-
electrons, respectively. Moreover, not the weak bonds of a molecule are broken during the 
ionization process, but rather stable fragment ions are formed. 
 
 
Figure 2.3. Electron-impact ion source 
 
Source
magnets
Filament
Repeller Trap
Sample entry
Ions
A
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Chemical Ionization (CI). The CI-method was developed to overcome the problem of too 
heavy fragmentation often observed in EI-MS, particularly with labile sample molecules. 
Glycoside derivatives, for example, do not show molecular ions (M•+) under EI-MS 
conditions. However, chemical ionization allows the formation of quasi-molecular ions by 
protonation in the positive ionization mode (formation of [M+H]+-ions) or deprotonation in 
the negative ionization mode ([M–H]–-ions), and thus the determination of the molecular 
weight of the rather labile molecules. 
The quasi-molecular ions are formed by proton-transfer reactions (or ion/molecule 
reactions) with a reactant gas (e.g. methane, iso-butane, ammonia) that was ionized by 
electron impact at 200 eV. The change from EI- to CI-MS mode is easy, as the same ion 
source is used. Only the "ion volume" where the ionization takes place (A, figure 2.3) has 
to be exchanged and filled with reactant gas. 
The main drawback of EI- and CI-MS is that the samples to be investigated have to be 
transferred into the gas phase by evaporation (heating) before the ionization and transfer to 
the analyzer. This cannot be achieved for many polar, non-volatile and large molecules – 
as most of the biologically interesting biopolymers and other natural products – by heating 
without decomposition of the samples. 
 
 
2.2.2. Ionization by Desorption 
Desorption methods were developed for non-volatile compounds. The idea was to deposit 
the sample on a solid support, in some cases together with a matrix, to transfer the support 
in the mass spectrometer, and to apply a particle beam rich in energy. The type of 
ionization depends on the nature of the falling particles and the matrix.  
Fast-Atom Bombardment (FAB). Samples are mixed with a low-volatile fluid (e.g. 
glycerin, thioglycerin, or 3-nitrobenzyl alcohol), and a thin layer of the solution is brought 
onto a plate and fixed in the ion source. The sample is then ionized by bombardment with 
fast neutral atoms like Ar or Xe. Usually, protonated and/or sodiated quasi-molecular ions 
([M+H]+ and/or [M+Na]+) are formed in the positive ionization mode, and deprotonation 
occurs in the negative mode ([M-H] –-ions). With the development of FAB, peptides with 
MW up to 3000 Da could be investigated with MS for the first time. 
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Figure 2.4. Fast-atom bombardment mechanism 
The relevance of FAB-MS strongly decreased the last few years. The principal reason is 
the emergence of other two further ionization methods, ESI and APCI, that are easier in 
handling and more versatile to apply. 
Matrix-Assisted Laser Desorption Ionization (MALDI). MALDI is an efficient and 
extremely sensitive technique with a wide application range. The measurements are 
performed in two steps. First, the sample is dissolved in a mixture of solvent and matrix. 
The most widely used matrices are α-cyano-4-hydroxycinnamic acid (HCCA), 2,5-
dihydroxybenzoic acid (DHB), or sinapinic acid (SA), depending the class of compounds 
under investigation. In a second step, the crystals that were built are irradiated with short 
and strong laser pulses, leading to the formation of ions. 
The role of the matrix is to co-crystallize with the sample molecules and to absorb laser 
energy. Therefore, the matrix molecules contain a chromophore with absorption maximum 
at the wavelength of the laser (e.g. the matrices given above are used for a N2-laser at 
337nm). The exact mechanism of material ablation and formation of charged matrix and 
molecules in the Maldi process are still poorly understood (Hillenkamp et al. 2007). It is 
generally accepted that the matrix absorb the laser energy, evaporate and transfer some 
energy to sample molecules. Quasi-molecular ions are formed by proton-transfer reactions 
during the evaporation process. Mainly [M+H]+, [M+Na]+, [M+2H]2+, or [M–H]– -ions are 
observed. 
sample
+ formation of ion clusters
desolvatation in several steps
quasi-molecular ions
solvent
(glycerin)
primary beam
(Ar0, Xe0)
collision cascade
[M+H]+,[M+Na]+, [M+K]+,[M-H]- ...
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The major drawback of Maldi-MS is the formation of very intensive matrix signals in the 
low mass range. A new approach has been developed recently to overcome ion suppression 
effects when low molecular weight compounds are analyzed. This method is based on 
dense arrays of single-crystal silicon nanowires (Go et al. 2005). Such a solid support 
absorbs the laser energy and transfers it to the sample molecules without evaporating. Only 
sample molecules are protonated and transferred to the gas phase. 
Because the laser beam is pulsed, MALDI do not produce continuously ions. A pulsed ion 
beam, together with the formation of mostly singly charged quasi-molecular ions, makes 
time-of-flight (TOF) the best type of mass analyzer. TOF is very sensitive and has an 
unlimited mass range, essential properties required for the analysis of large biomolecules. 
 
 Common matrices: 
 
 
 
 
Figure 2.5. Matrix-assisted laser desorption ionization 
MALDI became an unique method in many different domains such as proteomics and 
genomics, for the analysis of oligosaccharides, synthetic polymers, lipids, and even non-
covalent complexes of large molecules or taxonomy of bacteria (Hillenkamp et al. 2007).  
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2.2.3. Ionization via Spraying 
The demand for liquid chromatography-mass spectrometry (HPLC-MS) interfaces was the 
main motivation for the development of atmospheric pressure ionization methods in the 
1970’s and 1980’s. Thermospray was the first commercially available spraying technique 
(Vestal 1983). Later, atmospheric pressure chemical ionization (APCI) and electrospray 
ionization (ESI) were developed because these methods offer better sensitivity and 
reproducibility. Today, over 99% of the HPLC-MS applications are based on these two 
ionization techniques.  
Electrospray Ionization (ESI). A sample is dissolved in a rather polar solvent like, for 
example, H2O, MeOH, i-PrOH, CH3CN, or CH2Cl2, containing a volatile buffer like 
HCOOH, CH3COOH, TFA, NH4OAc, or Et3N. A high voltage (typically 3-4 kV) is 
applied to this solution that contain the preformed ions, and emerge from a thin capillary at 
a flow rate of around 0.5-500µl·min-1. The electrical fields cause the solvent to brake into 
fine threads that subsequently disintegrate into small droplets (figure 2.6). Quasi-molecular 
ions are generated from these droplets by a variety of ionization processes (Cole 1997).  
a) ESI 
 
 
b) APCI 
 
Figure 2.6. Direct comparison of a) ESI and b) APCI 
Initially, ESI-MS investigations were focused on small polar molecules. The method 
became essential only when the group of Fenn showed in 1988 that multiple-charge ions 
can be generated from proteins by ESI (Fenn et al. 1990). This allows the analysis of 
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molecules with MW > 100’000 using ‘conventional’ mass analyzers (e.g. quadrupole, ion 
trap, sector field instruments) with a mass range of 100-3’000 m/z.  
Electrospray is the mildest of all ionization methods allowing investigations of thermal 
labile molecules, metal complexes, or the study of non-covalent interactions. It is also 
often connected to liquid chromatograph for the analysis of complex mixtures like 
biological fluids or protein digests. 
 
Atmospheric-Pressure Chemical Ionization (APCI). A sample solution (flow rate 200-
1000 µl·min-1, same solvents and buffers as in ESI) is sprayed at atmospheric pressure 
trough a heated capillary (250-450°C) with N2 as sheath gas. A corona needle (3-5 kV) 
ionizes first N2 that is in excess, the formed N2•+ ions react with gaseous solvent molecules, 
and acidic species like e.g. CH3OH2+ or H3O+ are formed. These acids finally ionize the 
sample molecules via proton-transfer reactions in the gas phase. Because protonation 
occurs in the gas phase, APCI may form quasi-molecular ions from sample molecules with 
lower proton affinities than with ESI. 
Practically, the change from ESI to APCI with a given mass spectrometer is very easy 
because only the front of the ion source containing sprayer and corona needle has to be 
exchanged. This operation can be done without venting the instrument. 
The choice of the ionization mode, ESI or APCI, is made according the polarity and the 
molecular weight of the sample: 
 
Figure 2.7. ESI versus APCI in function of the molecule properties 
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2.2.4. Overview of the ionization methods 
The ionization method is chosen according to the following criteria: 
- For volatile, not too polar samples, EI-MS is generally appropriate. If no molecular 
ions are observed by this method, then CI-MS is used, which normally allows the 
determination of the molecular weight of the sample molecule. 
- For macromolecular compounds contained in only a few microliters of sample 
solution, MALDI-MS is the method of choice.  
- ESI/APCI-MS has a broad spectrum of application. They are used for various 
organic molecules, from simple to complex. The only prerequisite is that the 
sample molecules contain at least one functional group. Furthermore, ESI is the 
best method for the study of non-covalent interactions or complex formation. 
 
Ionisation method Ionisation agent Results Typical applications 
Evaporation 
EI 
Electron Impact 70 eV Electrons 
Reproducible spectra 
containing many 
fragment ions 
Volatile compounds with 
low MW. 
Structure elucidation.  
 CI 
Chemical Ionization 
Ions in the gas phase 
(NH4+) Protonated molecules 
Volatile compounds with 
low MW. 
MW determination 
Desorption FAB, MALDI Beam of energy rich atoms, ions, or photons  
Entire Quasi-
molecular ions 
formed via redox or 
acid/base reactions 
None volatile compounds 
from middle (FAB) up to 
high MW. 
MW determination 
Spraying 
ESI, APCI 
Electrospray, 
Atmospheric Pressure 
Chemical Ionization 
Electrical field on 
micro-droplets or 
vapor. 
Entire Quasi-
molecular ions 
(several time charged 
in ESI) 
None volatile, mid- to polar 
compounds with low to 
high MW. 
MW determination 
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2.3. Analyzers  
There are three fundamental ways to separate ions. In all cases, ions are separated 
according to their mass-to-charge ratios (m/z). A beam of charged particles can be deviated 
by electric or magnetic fields, ions can be trapped and mass selectively ejected or they can 
be separated by time-of-flight.  
Modern mass analyzers were always sophisticated apparatuses produced from elements 
that approach the state-of-the-art in electronics, vacuum systems, magnet design, precision 
machining, and computerized data acquisition, and processing. They are the core of a mass 
spectrometer and its most expensive part. 
The most widely used analyzers will shortly be presented hereafter. 
 
2.3.1. Deflection of ion beams 
A continuous ion beam can be deflected by momentum in a magnetic field, by electric 
fields, or by linear radio frequency. 
Sector-Field Instrument. Sector-field instruments are typically fitted with EI-, CI-, or 
FAB-ion sources. They represent the earliest MS-instruments and are still in use because 
of their performance in mass resolution and accuracy. Typically two sectors, which are 
magnets or strong electrostatic analyzers, are coupled in series.  
 
Figure 2.8. Finnigan MAT95 two-sector-field instrument (Brunnée 1997) 
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Sector-field analyzers have high resolution and high accuracy capability. These 
performances allow the determination of chemical formula of the sample molecules 
investigated by EI-, CI-, or FAB-MS. Beside organic mass spectrometry, sector-field 
instruments are widely used in isotope ratio determination. With this type of experiments, 
the origin or age of a sample can be determined. This ability is applied in archeology (age 
of a finding), in food industry (geographic origin of an additive), or in doping analysis 
(distinction between natural or synthetic steroids anabolic). 
 
Linear Quadrupole. Four parallel rods build a quadrupole analyzer. A direct current (DC) 
is applied on an opposite pair of these rods, and a radiofrequency (RF) voltage on the 
other. 
  
Figure 2.9. Schematic view and picture of a quadrupole mass analyzer (Gross 2004) 
At a defined DC and RF voltage, only the beam of ions with a specific mass-to-charge 
ratio has a stable trajectory (m/z 100 in figure 2.10). This means that only ions of this m/z 
reach the detector and that all other ions are filtered out. 
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Figure 2.10. Quadrupole at specific voltage 
The linear quadrupole analyzers were initially developed to being coupled to gas 
chromatographs. Today, they are most used systems because of their relatively cheap prize, 
robustness, and versatility. They are generally fitted with EI-, CI-, ESI-, as well as APCI-
ion sources, and often coupled to gas and liquid chromatographic systems. Quadrupoles 
are also used in tandem mass spectrometry (MS/MS) as filters, collision cells, or analyzers. 
 
2.3.2. Trapping Ions 
Three methods of trapping ions are established: the quadrupole ion trap, operating at 
normal resolution, and Fourier-transform ion cyclotron resonance (FT-ICR) and orbitrap, 
both as high-end mass spectrometers. 
Since in trapping analyzers all ions are collected simultaneously over a variable duration, 
they are very sensitive. However, space-charge effects due to overloading have to be 
avoided otherwise resolution and accuracy will be lost. Modern ion-trapping instruments 
have an implemented automatic gain control to overcome this drawback.  
 
Quadrupole Ion Trap (QIT). A ring together with a gap and an end cap electrode build a 
quadrupole ion trap. This three dimensional arrangement is partially filled with an inert 
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gas, typically He at 3-5·10–5 mbar. This gas is used for cooling the ions once they have 
entered the trap and before the mass analysis is performed.  
With such an instrument, several steps are necessary to record a mass spectrum. After the 
trap was emptied, charged particles are collected at a specific DC- and RF-voltage and 
gathered in the center of the analyzer. Then, the ions are mass selectively ejected to the 
detector. 
 
Figure 2.11. Quadrupole ion trap (March 2000) 
If required, automatic MS/MS experiments can be performed. In this case, all the charged 
particles that enter the mass spectrometer are collected. Then the precursors ions are 
isolated, excited and dissociation reactions occurs as the trap is filled with He. Finally, the 
formed fragment ions are mass selectively ejected and recorded. With quadrupole ion trap, 
up to the 10th generation of product ions (MS10) can be studied. This is particularly useful 
when, for example, glycosyl derivatives are investigated with ESI-MSn. The first 
generation of product ions (or MS2) shows often only the loss of the glycosyl group. If 
structure information concerning the core of the molecule, e.g. an alkaloid, a flavonoide, or 
a steroid is required, then further generations of products ions could to be generated. 
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Because of their mass range from 40 up to 3’000 or even 6’000 m/z for some instruments, 
EI-, CI-, ESI-, and APCI-ion sources are the ionization methods that best fit QIT mass 
analyzers. Automatic gain control, automatic MS/MS experiments, and high scan rates are 
the reasons for the broad application spectrum of QIT, in particularly in combination with 
GC and HPLC. 
 
Linear Ion Trap (LIT). Linear ion traps are available since 2002 (Hager 2002). They 
combine the principals of operation and the properties of linear quadrupoles and QIT. They 
can accumulate charged particles, excite them axially or linearly, and they can act as 
normal scanning mass analyzer. They are fast, extremely sensitive because of less space-
charge-effects compared to QIT, and they are often used as MS/MS device coupled to 
high-end FT-ICR or orbitrap analyzers.  
 
Figure 2.12. Linear ion trap 
 
Fourier-Transform Ion Cyclotron Resonance (FT-ICR). Together with the orbitrap, FT-
ICR are the only instruments that record mass spectra in a non-destructive way. The 
charged particles are collected in the center of a cubic or cylindrical cell, which is placed in 
the center of a superconducting magnet. After excitation, ions with different m/z ratios 
rotate at different frequencies around the axis of the cell. A detection electrode finally 
records the magnetic fields they induce. The sum of the frequencies is ‘Fourier-
transformed’ and a mass spectrum is generated. 
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Figure 2.13. Fourier-transform ion cyclotron resonance analyzer (Marshall et al. 1998) 
Despite the costs of FT-ICR instruments, which are proportional to the strength of the 
magnet, this relatively old technology is still in use because of its unequaled performances 
in resolution and accuracy (sub-ppm with external calibration). As a highlight, over 11’000 
compositionally distinct components of a single ESI-FT-ICR-MS of crude oil in the mass 
range 200-1000 m/z could be resolved (Hughey et al. 2002).  
 
Orbitrap. The orbitrap mass analyzer is the only instrument based on a fully new mode of 
operation that was invented the last 20 years. It was invented by Makarov in 2000, was 
first connected in 2003 to a high performance liquid chromatograph and already 
commercialized in 2004 (Makarov 2000). The ions are trapped and analyzed by rotation 
around a central rod. As for FT-ICR, different ions have distinctive frequencies, and the 
magnetic fields they induce are recorded and ‘Fourier transformed’. Finally, software 
transforms the ion frequencies to a m/z scale. 
  
Figure 2.14. Orbitrap mass analyzer (Hu et al. 2005) 
Orbitrap instruments reach resolutions and accuracies that are close to those obtained from 
FT-ICR instruments; however, they have a higher scan rate and they operate without 
superconducting magnets. Therefore, they are lower in price and easier to maintain. 
  Recent Applications of Mass Spectrometry 24 
Orbitraps are offered in combination with a LIT, which allows several types of 
experiments as, for example, full scan MS and MS/MS at normal and high accuracy, to be 
performed in a single HPLC run.  
 
2.3.3. Time-of-flight 
The linear time-of-flight (TOF) mass analyzer is the simplest of all the mass analyzers. An 
analysis is based on the acceleration of a group of ions toward a detector by an accelerating 
potential, giving all of the ions the same kinetic energy. As the ions have the same energy 
but different masses, the ions of lower mass reach the detector first due to their higher 
velocity. Hence, the analyzer is called time-of-flight because the mass is determined from 
the ions’ time of arrival.  
TOF has enjoyed a renaissance with the development of delayed extraction and reflectron 
technologies that led to an increase of performance. The delayed extraction is a technique 
applied in MALDI, which allows ions to be extracted from the ionization source after 
cooling and focusing (Brown et al. 1995). The reflectron is an electrostatic mirror which 
effects higher resolution by increasing the path length and through kinetic energy focusing 
(Mamyrin 2001).  
 
 
Figure 2.15. Reflectron time-of-flight mass analyzer (Wollnick 1993) 
Today, TOF instruments are widely used for MALDI-, HPLC/ESI-, and GC/EI-MS 
applications. They have high scan rates (up to 100 Hz), high sensitivity and good 
resolution. Their mass range is principally only limited by the energy liberated when ions 
collide with the detector. 
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2.3.4. Hybrid Instruments 
Individual mass spectrometers can be constructed by combining different types of mass 
analyzers into a single instrument. The driving force to do so is to get powerful MS/MS 
instruments by combination of the advantageous properties of each mass analyzer they are 
composed of.  
Table2.1. Most extensively used hybrid instruments 
MS1 MS2 Comment 
Sector field Quadrupole or QIT Were first developed but fastidious maintenance 
Quadrupole TOF Sensitive, good resolution 
LIT FT-ICR Ultrahigh resolution and mass accuracy 
LIT Orbitrap High resolution, mass accuracy and sensitivity 
 
The best-established hybrid mass analyzer is probably the quadrupole time-of-flight. This 
analyzer is typically coupled to ESI ion sources, because it combines the stability of a 
quadrupole analyzer with the high sensitivity, and accuracy of a time-of-flight reflectron 
mass analyzer. The quadrupole can either act as an analyzer in an ordinary quadrupole 
instrument to scan across a specified m/z range, or it can also be used to selectively isolate 
a precursor ion that is then directed to a collision cell to induce fragmentation. The TOF 
reflectron mass analyzer then analyzes the resulting fragment ions. 
 
Figure 2.16. Hybrid quadrupole time-of-flight mass analyzer 
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2.4. Hyphenated Methods 
Chromatographic detectors, such as flame ionization detector frequently used in GC or 
variable wavelength detector in HPLC, deliver a chromatogram that represent the mass 
flow eluting from the chromatographic column. Using a mass spectrometer instead, offers 
an additional dimension of information about the structure of the analyte. 
Often, the analysis of complex mixtures requires the combination of separation techniques 
and mass spectrometry. The first hyphenated method was the coupling of gas 
chromatography with mass spectrometry (GC-MS), and soon, GC-MS became a routine 
instrumentation (Message 1984). The desire to couple HPLC with MS was the driving 
force for the development of the atmospheric-pressure ionization methods (ESI and APCI). 
Coupling of capillary zone electrophoresis, and capillary electrochromatography to MS 
followed (Shintani et al. 1997). 
Mass analyzers are highly selective, and coupling of chromatographic systems increase 
their sensitivity by concentrating the sample on the column. Such an additional beneficial 
effect allows effective quantification work. Therefore, GC- and HPLC-MS are widely 
used, for example, in food and environment chemistry, medicine, and forensics.  
 
2.4.1. Gas Chromatography – Mass Spectrometry (GC-MS) 
GC columns consist of coated glass capillaries of usually 0.22mm ID. In GC-MS, they are 
directly interfaced to EI/CI ion sources. The separation of the components occurs through 
interactions of the analyte with the stationary phase of the column (different polarity) and 
by elevating the temperature of the oven (different vapor pressure). Helium gas is usually 
used as carrier gas. The compounds eluting from the GC column are then quantitatively 
transferred into the ion source during a short time interval, just sufficiently long to acquire 
a few mass spectra. This allows the analysis of samples in the low nanogram region. 
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Figure 2.17. GC-MS instrument 
The injector of the chromatograph and the transfer line are always at high temperature, 
even when the oven containing the column is not hot. The technique requires therefore a 
certain level of volatility and thermal robustness of the analyte. In order to adapt a 
substance to these properties, derivatization is well established. The most frequent 
procedures are silylation, acetylation, methylation, and fluoralkylation of XH groups. 
These derivatizations usually lead to a decrease of polarity and to enhanced volatility of 
the sample compounds.  
 
2.4.2. Liquid Chromatography – Mass spectrometry (HPLC-MS) 
Investigations into the coupling of HPLC and MS started some 30 years ago, in the early 
1970’s. During the first 20 years most of the attention had been given to finding solutions 
to interface problems or developing new technologies; today, focus is almost exclusively 
given to the application of the available techniques. Technological problems appear to be 
solved, and from the wide variety of interfaces developed over the past years, basically 
only two remained, ESI and APCI (Niessen 2006). 
In HPLC, the general principal of chromatographic separation is based on a liquid/liquid or 
solid/liquid repartition of analytes between a particular stationary phase in a HPLC column 
(or capillary) and a mobile phase that is pumped through the column. The variation of the 
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mobile phase composition throughout a chromatographic separation is called gradient 
elution; it normally allows a better and faster separation of components.  
After the HPLC pump, a UV detector at variable wavelengths (to obtain chromatograms) 
or photodiode array (to obtain chromatograms and absorption spectra of the components) 
is often coupled prior to an MS instrument. With such an instrumental setup, information 
about chromophores, molecular weight and structure (MS/MS analyzer is required) of 
mixture components can be obtained in a single HPLC run.  
 
Figure 2.18. Standard HPLC-UV-ESI-MS instrument fitted with a microbore HPLC column 
In order to increase the sample concentration at the detector, HPLC instruments working 
with lower flow rates have been developed. For a defined amount of sample injected, the 
limit of detection is more than three orders of magnitude lower if nanoHPLC is used 
instead of standard chromatography. For this reason, the nano-HPLC-MS coupling is 
routinely established in most of the proteomic laboratories that analyze digests of protein 
samples. 
Table2.2. Effect of the HPLC column diameter on the sensitivity 
Type Column ID Injection vol. [µl] Flow Detector conc.rel. 
Standard 4.6 mm 5-20 1000 µl·min-1 1 
Narrowbore 1-2 mm 0.5-5 40-300 µl·min-1 20-5 
microHPLC 300 µm 0.1-0.3 4 µl·min-1 235 
nanoHPLC 75 µm 0.05-0.1 200 nl·min-1 3800 
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2.4.3. Tandem Mass Spectrometry (MS/MS) 
Whereas the ionization techniques and mass analyzers developed in the mid-1980s are 
crucial to the application of MS to biological compounds, the technique of MS/MS is an 
equally important factor in the contribution to the field. As the name implies, MS/MS 
involves two stages of MS. In the first stage, ions of a desired m/z are isolated from the rest 
of the ions emanating from the ion source. These isolated ions (so-called precursor ions or 
parent ions) are then induced to undergo chemical reactions by increasing their internal 
energy, usually via collision with an inert gas (He or Ar). This process is called ‘collision 
induced dissociation’ (CID). Finally, the fragment ions are separated and recorded. 
There are two types of MS/MS instruments, namely ‘tandem in space’ and ‘tandem in 
time’. ‘Tandem in space’ instruments are consisting of more than one mass analyzer and 
each step of the MS/MS investigation is performed at a different place in the instrument 
(MS I and MS II). Beam-type analyzers like triple quadrupole, time-of-flight, or sector-
field quadrupole are used in tandem-in-space instruments.  
Ion traps and FT-ICR are instruments performing ‘tandem-in-time’ experiments. The 
various stages of MS/MS – ion collection, isolation, excitation, and analysis of the 
fragment ions – are performed in the same analyzer but separated in time. Tandem-in-time 
instruments have the advantage of being able to do multiple stages of MS/MS (MSn) 
experiments with a single mass analyzer.  
MS/MS experiments are often used for structure elucidations when soft ionization 
techniques (e.g. ESI, APCI, or Maldi) are in employed. These ion sources generate mainly 
quasi-molecular ions, and the spectra contain only low structure information. It is 
noteworthy that for HPLC-MS applications, other scan modes are possible that 
significantly improves the selectivity (figure 2.19). For example, the monitoring of certain 
collision-induced fragmentation reactions by selected reaction monitoring (SRM) – in this 
case MS I and MS II are fixed at reaction specific m/z values – lead to chromatograms with 
a greatly improved S/N ratio. This technique was applied for the quantification of 
taurolidine in human plasma (see Chap. 5.3). 
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Figure 2.19. Analysis mode in tandem MS (Kinter et al. 2000). 
Although SRM is the method of choice in quantitative bioanalysis, precursor-ion and 
neutral-loss analysis modes are particularly useful in quantitative analysis and screening of 
food or environmental samples for contaminants. For example, when a glycosylated 
peptide is dissociated, one of the product ions is m/z 204, which is a glycosyl fragment. By 
setting MS II to only m/z 204, MS I can be scanned to sequentially pass all the ions emitted 
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from the ion source, but only those ions that dissociate to m/z 204 will be detected 
(precursor ion scan). This means that the glycosyl derivatives will be the only components 
of the mixture that show a signal on the HPCL-MS/MS chromatogram. Precursor-ion scans 
or neutral-loss scans have to be performed on tandem-in-space instruments. Thus, for 
screening mixtures, beam instruments (e.g. triple quadrupoles) have a definite advantage 
over ion trap instruments. 
Today, tandem mass spectrometry is an established method with plentiful applications, e.g. 
in elucidation of structures, determination of fragmentation mechanisms, determination of 
elementary compositions, applications to high-selectivity and high-sensitivity analysis and 
observation of ion-molecule reactions. In proteomic applications for example, the 
sensitivity levels are so low that sequencing and identification of proteins can be 
accomplished on the same amounts of material used by biomedical investigators in routine 
experiments (Kinter et al. 2000).  
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III. OWN DEVELOPMENTS 
Coupled with different separating methods such as gas chromatography (GC) or high-
performance liquid chromatography (HPLC), mass spectrometry gained a capacity to solve 
problems that were inadequately addressed by other analytical tools. A large number of 
ionization methods and type of analyzers have been developed and combined in various 
ways (see above). Nowadays, to a great part, the challenge in MS is the selection, 
depending on the material of interest, of the best combination of separating and detecting 
methods to suite actual needs. 
The success of MS-analyses is strongly dependent on the procedure of sample preparation. 
In the works presented hereafter, the analytes were of medium to high polarity and low 
volatility, and part of complex mixtures. In order to reduce sample degradation, to 
minimize contamination and to increase sensitivity and efficiency, sample preparations 
were chosen as straightforward as possible. A method based on GC-MS has never been 
taken in account because the polar compounds of interest, an extraction step followed by 
derivatization reactions would have been necessary. This is difficult to achieve without 
discrimination of some of the components, in particular, when the analytes are highly 
soluble in water and have to be quantified.  
For these reasons, methods based on the analyses of crude mixtures, HPLC 
chromatographic separation, on-line recording of UV-absorption spectra and mass 
spectrometry, were developed. The choice of the MS instrument was mainly dependent on 
the instrument performance. The performance can typically be defined by the following 
characteristics: accuracy, resolution, mass range, tandem analysis capabilities, and scan 
speed. In combination with liquid chromatography, two types of ions sources, ESI and 
APCI, can be considered. In the following table, the mass analyzers typically used for 
electrospray and their performances are displayed. 
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Table 3.1. General comparison of ESI-mass analyzers and their properties 
 Quadru-
pole 
Ion Trap Time-of-
Flight 
Reflectron 
Magnetic 
Sector 
FT-ICR Q-TOF 
Accuracy 100 ppm 100 ppm < 5 ppm < 3 ppm < 1 ppm < 5 ppm 
Resolution 2’000 4’000 15’000 30’000 100’000 10’000 
m/z range 4’000 4-6’000 10’000 8’000 10’000 10’000 
Scan Rate ~2 Hz ~5 Hz 50 Hz 0.1 Hz ~1 Hz ~20 Hz 
MS/MS MS2 (QqQ) MSn MS MS2 MSn MS2 
Comments Low cost, 
Ease of 
pos/neg ions 
switching 
Low cost, 
Ease of 
pos/neg ions 
switching 
Good accuracy 
and resolution 
High 
accuracy but 
low scan rate 
High 
resolution & 
accuracy, 
expensive 
Good 
accuracy 
and 
resolution 
 
All experiments were performed with a triple stage quadrupole (QqQ) and with a 
quadrupole ion trap (QIT), both couple to a HPLC system. These highly automated 
systems are able to produce even hundreds of analyses per day. Such automation requires 
samples of the same type to be treated by an analytical protocol that has been carefully 
elaborated by an expert before. A successful and straightforward data interpretation is 
strongly dependent from the quality of the data obtained. Sample preparation procedure, 
choice of the HPLC conditions (column, gradient, and solvents), selection of the ionization 
method, MS parameters, and, if necessary, MS/MS experiments have to be well thought-
out for a good method optimization.  
Recently, we have developed several analytical methods for the structure elucidation of 
unknown natural products or the study of biosynthesis pathways in plants (Chesnov et al. 
2002). For example, more than 80 polar organic compounds could be identified from 10mg 
pollen of Hippeastrum flowers, or labeled precursor molecules were added to the growth 
medium and labeled biotransformed products detected after there were assimilated from 
Aphelandra plants. 
The experimental setup shown in Scheme 3.1 consists of an HPLC on-line coupled with an 
ultraviolet diode array detector (UV-DAD) and either APCI-, or ESI-MS and MS/MS. 
Such systems are particularly advantageous for the analysis of substances that are available 
only in traces. Additionally, the analysis of crude material decreases the probability of 
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material loss or oxidation (formation of artifacts) during the handling of the sample before 
it is introduced into the mass spectrometer. HPLC-UV(DAD)-ESI-MS gives important 
primary information about the structural nature of the compounds, i.e. the type of 
chromophores present, and, of course, the molecular weight of the analyzed compounds. 
ESI- and APCI-MS are soft and sensitive ionization techniques and usually yield quasi-
molecular ions with low fragmentation. This is particularly suitable for the investigation of 
thermolabile compounds such as e.g. polyamines, flavonol, or peptide/protein derivatives. 
The present work will give an insight into a selection of HPLC-UV(DAD)-ESI-MS and 
MS/MS applications. After adaptation of the experimental setup, investigations as versatile 
as structure elucidation, metabolomic profiling, or pharmacokinetic studies of thermally 
unstable compounds can be performed. 
The central research performed in our laboratories will be shortly introduced hereafter. All 
studies were done using hyphenated mass spectrometric methods, and mass spectrometry 
was a key tool for solving the problem. 
 
Scheme 3.1. Mass spectral fragmentation of the terminal part of the [M + H]+ ions of the IndAc 
pentamine derivatives  
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A) Structure elucidation of natural products – Polyamine derivatives from spider 
venom 
Biologically active compounds from different natural sources have attracted the attention 
of scientists for hundred of years. Their constituents were isolated and their further use as 
possible medicines tested. A more sophisticated separation, characterization and synthesis 
of natural compounds could be achieved with the development of modern analytical and 
organic chemistry. Nevertheless, it was only possible to analyze those substances that were 
present in at least milligram amounts. The separation and characterization of minor 
components that were present in natural objects in trace amounts was unlikely by classical 
methods. 
In the last twenty years, spider venoms were widely investigated with the aim to elucidate 
their structures and to test their biological activity (Escoubas et al. 2000; Rash et al. 2001). 
Interesting results were obtained during these studies. In spider venom, depending on the 
species, one could find in different ratios various compounds, such as amino acids, purine 
bases, polyamines, acylpolyamines, peptides, polypeptides and proteins. 
In our laboratories, methods based on HPLC, on-line coupled with UV-diode array 
detection, and APCI- or ESI-MS/MS (scheme 3.1), were used for the first time to 
characterize low-molecular-weight compounds, in particularly polyamine derivative, 
present in spider venoms (Chesnov et al. 2000; Horni et al. 2000; Chesnov et al. 2001). 
After injection, the sample is separated into its components on the column according to 
their polarity. After separation, they pass through the UV(DAD) detector, and the 
chromophores present are determined from the UV spectra that are recorded continuously 
during the whole measurement. The sample is sprayed into the mass spectrometer as soon 
as it has passed the UV cell. The molecular weight of a substance can then be estimated 
instantly from the quasi-molecular ions [M+H]+. Of course, all the collected information, – 
the mass spectra of separated or partly-separated compounds with their retention times, as 
well as their UV spectra – is rather incomplete because mild ionization prevents any 
structural information from being obtained, other than the molecular weight and the 
chromophores. 
More data could be obtained using the technique of MS/MS. Fragment ions obtained by 
collision-induced dissociation (CID) of the quasi-molecular ions, give additional structural 
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information. Our first tandem mass spectrometry experiments were performed on a triple-
stage quadrupole mass spectrometer (QqQ) in the product ion scan mode. The selected 
precursor ions collided with an inert gas (Ar), got more internal energy and fragmented. A 
connected second mass spectrometer (Q3) analyzed the fragment ions.  
 
Figure 3.1. Agelenopsis aperta venom: acylpolyamine-containing fraction analyzed by HPLC-
UV(DAD)/APCI-MS. a)–g) and j)–o) (EIC) of quasi-molecular ions m/z 417, 449, 490, 506, 465, 
522, 380, 396, 453, 469, 433. g) RIC; h) UV Detection at 254 nm. AU = arbitrary unit. The starred 
signals belong to compounds co-eluting with the major constituents, where the chromophore type 
was suggested from MS/MS data. 
If an HPLC is connected to a triple quadrupole instrument, structure elucidation of the 
interesting compounds has to be performed in two steps. The masses of interest have been 
to be determined in one run and then, structure elucidation of a unique m/z value can be 
performed in a second run.  
Investigations of the venom of Agelenopsis aperta spider, shown in figure 3.1 demonstrate 
how laborious such analyses can become if a complex sample is investigated (Chesnov et 
al. 2001). This approach, nevertheless, allowed the characterization of no less than 38 
acylpolyamines with 11 different molecular weights in the venom of A. aperta spiders 
((Manov et al. 2002); for a general structure, see e.g. ARG636 in figure 3.2). 
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Only 11 acylpolyamine derivatives were known in this venom before (Quistad et al. 1990). 
The structures of these main components were elucidated after an extensive procedure of 
first fractionation/purification of the whole venom by HPLC, then individual fraction 
analyses by fast atom bombardment (FAB) mass spectrometry. 
 
Figure 3.2. Structures of polyamine spider toxins exemplified by Arg 636. 
 
The next improvement of the analytical procedure was achieved with the use of quadrupole 
ion trap mass analyzer. This type of mass spectrometer is able to select and to fragment 
automatically precursor ions registered during ESI-MS in the full scan mode. Quasi-
molecular ions are trapped, the product ions of interest segregated by mass and further 
fragmented by collision with He. This makes structure elucidation of unknowns in 
complex mixtures much faster and more sensitive. Information about the molecular weight 
and structure of many unknowns can be gained from a single HPLC run. 
A few milligrams of lyophilized crude venom of Larinioides folium spiders containing also 
salts, peptides, or proteins, was necessary for the study its polyamine derivatives content 
by HPLC-UV(DAD)-MS/MS (Eichenberger et al.). Combined with H/D-exchange 
experiments for the determination of the number of exchangeable protons, and amino acid 
analysis, as many as 41 polyamine derivatives could be identified in this complex venom 
(figure 3.3). 
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Figure 3.3. 3D-Plot of retention time (tR) vs m/z and rel. int. of an HPLC-ESI-MS run with the 
lyophilized spider venom of L. folium. 
 
The next level of difficulty is defined by the characterization of free linear polyamine 
derivatives containing four, five, or six N-atoms, and is presented in Chap. 5.1 hereafter. 
Some of constituents found there were N-hydroxylated, guanidylated, or acetylated with a 
UV-inactive group. Only a few examples of non-acylated polyamines containing more 
than four N-atoms were known. Beside caldopentamine (PA33331) in the silk glands and in 
the heads of the spiders Nephila clavata and Araneus ventricosus (Hamana et al. 1991), 
extended free polyamines were only found in bacteria (Hamana et al, 1992). They were 
characterized either by GC-MS after their derivatization with heptafluorobutyric anhydride 
(HFBA, (Niitsu et al. 1993)), or by HPLC and fluorescence detection of the o-
phthalaldehyde (OPA) reaction products (Hamana et al. 1998). 
                                                
1 The abbreviation PA stands for polyamine; the figures designate the number of methylene in-between the 
several N-atoms Bienz, S., Detterbeck, R., Ensch, C., Guggisberg, A., Häusermann, U., Meisterhans, C., 
Wendt, B., Werner, C. and Hesse, M. (2002). "Putrescine, Spermidine, Spermine, and Related Polyamine 
Alkaloids." Alkaloids 58: 83-338.. 
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Our approach of on-line HPLC-UV(DAD)-ESI/APCI-MS and MS/MS experiments 
became more difficult as soon as the lypophilic head was missing in the polyamine 
derivatives. First, the HPLC-UV detector does not register such compounds. Moreover, 
they are now particularly polar and therefore interactions with the C18-chains of the reverse 
phase HPLC column extremely weak. The results are retention times close to the dead 
volume and problems of co-elution.  
Only the introduction of end-capped C18-columns of good quality with 3µm particle size, 
which are more or less stable under 100% aqueous conditions, allowed the separation and 
characterization of the free polyamines. In addition, discussion concerning the 
biosynthetical pathway leading to the formation of acylpolyamines in spider venoms 
became possible.  
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B) Mechanisms of Tandem Mass Spectrometric Fragmentations 
Many natural products like peptides, oligonucleotides or saccharides are thermally labile 
compounds and failed to be investigated by long-established electron impact mass 
fragmentation at 70 eV. The same is true for polyamines (e.g. spermidine and spermine) 
and their derivatives. To render such molecules more heat resistant, they were first 
converted to their more stable N-acetyl derivatives (Bosshardt et al. 1974). The mass 
spectral fragmentation of the acetyl derivatives then allows the deduction of general rules 
for this class of compounds. 
Because the available amounts of the toxins are often very small and they have high 
polarity, the above-mentioned acetylation method is not useful and analytical systems 
based on the soft ionization techniques ESI and APCI were developed. To obtain structural 
information from quasi-molecular ions [M+H]+, [M+nH]n+, or [M+Na]+, low energy 
collision induced dissociation (CID) with argon in a triple stage quadrupole or with helium 
in an ion trap instrument is the method of choice (Biemann et al. 1987; Fenn et al. 1989). 
In fact, polyamines such as spermine are so reactive that they even decompose in the ESI 
ion source if the lens voltages are not very well optimized; under such inadequate 
conditions, they give similar spectra to those obtained from CAD experiments. 
The reactivity of quasi-molecular ions under CID conditions has been studied in detail 
principally for proteins and peptides (Kinter et al. 2000). This research was catalyzed by 
the tremendous development of proteomic sciences in the nineties; however, the 
fragmentation behavior of polyamine derivatives was scarcely known, particularly because 
of a lacking of synthetic reference material. For this reason, new synthetic pathways based 
on solid phase technologies have been developed (Manov et al. 2002).  
Measuring thoroughly characterized reference structures is not sufficient to obtain 
evidence of the mechanistic pathway of CID fragmentations. Therefore, reference 
compounds were labeled. The easiest labeling reaction is the H/D-exchange of all acidic 
H-atoms with deuterated solvent (e.g. CD3OD or D2O). After carefully flushing of the ESI 
ion source in order to avoid back exchange, MS/MS studies can be performed on 
molecules containing fully deuterated amine, amide, hydroxyl, or acidic groups (Bigler et 
al. 1995). These types of experiments allowed us to uncover an unexpected neighboring 
group participation fragmentation reaction in cinnamic acid derivatives of diamines 
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(Scheme 3.2). Existence of this mechanism was further confirmed by MS/MS analyses of 
the meta-substituted cinnamic acid as well as the diaminopropane and heptane derivatives. 
These compounds showed much stronger signals for the product corresponding to the four-
center cleavage mechanism B, i.e. fragment ion m/z 93 having one deuterium atom less. 
 
Scheme 3.2. Mass spectral fragmentation of the diamino cinnamic acid derivatives under CID 
conditions. 
 
 
The synthesis of all acylpolyamines that could be considered in a spider venom sample is 
extremely time consuming. For this reason, a method for structure elucidation of 
acylpolyamines based on MS/MS data only is preferred, but requires a comprehensive 
understanding of fragmentation mechanisms.  
For the first time, 15N-labeled acylpentamines were synthesized by Bienz and coworkers 
(Manov et al. 2004). They were used to verify the hypothesis of (i) a trans-amidation 
reaction, (ii) a cascade of transamination reactions, or (iii) a stepwise fragmentation of the 
sample molecule. 
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Scheme 3.3.  
 
The MS/MS analyses of the 15N-labeled materials revealed the presence of fragment ions 
of the internal portion of the acylpolyamine (in bold on figure 3.4), which excluded the 
mechanism of transamidation (i). However, the mechanisms (ii) and (iii) can still not be 
distinguished with the results obtained. 
 
Figure 3.4. 15N-Labeled polyamine derivatives. 
To summarize, the 2nd paper demonstrates that structural elucidations of polyamines and 
their derivatives based on HPLC-UV(DAD)-APCI-MS and -MS/MS is only possible by 
comparison with synthetic material and require a profound knowledge of the fragmentation 
behavior under CID conditions, especially in the case of co-eluting isomers. Their identity, 
in such an extreme case, could only be revealed due to the specific fragmentation behavior 
of the several structural isomers that could only be studied, however, with the pure labeled 
compounds.  
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C) Drug Metabolism and Quantification 
Nature is an excellent source of new drugs or, more commonly, of lead candidates to 
drugs. Of the 20 most important drugs in 1999, 9 of them were derived from natural 
products (Harvey 2000; Silverman 2004). One approach to pharmacological research is the 
study of drug metabolism and the isolation of metabolites, the drug degradation products. 
On the one hand, these compounds may show a stronger or a different interesting 
pharmacological activity and, on the other hand, they might be responsible for side effects. 
Research in drug metabolism is strongly based on HPLC-MS and MS/MS. The 
investigations done in our laboratories on amiodarone (AMI) were chosen as an example. 
This compound, which was initially developed 40 years ago as an antianginal drug, is still 
considered as one of the most effective antiarrhythmic agents. However, AMI therapy is 
accompanied by a variety of severe adverse effects, including pulmonary toxicity, 
hepatotoxicity, and thyroid dysfunction. Since mono-N-desethylamiodarone (MDEA) was 
the only known metabolite of AMI in humans, we tried, in collaboration with the 
university hospital of Zurich, to study AMI  metabolism more in detail.  
Preliminary studies have shown that mammals, in particular rabbits, are biotransforming 
AMI to MDEA as well as to three other HPLC-UV-detectable compounds. Therefore, 
extracts obtained from rabbit liver microsomes were used first. The first compound that 
could be identified by HPLC-MS/MS was a hydroxylated derivative of MDEA (3’OH-
MDEA). It is noteworthy that NMR was necessary to allege the exact position of the 
hydroxyl group (Ha et al. 2001; Ha et al. 2001). This new substance was then synthesized 
(Wendt et al. 2002) and finally tested for it effects on lung cell by looking for it toxicity 
toward alveolar macrophages (Quaglino et al. 2004). 
Experiments with human plasma could also been performed succefully (Ha et al. 2005). 
Two further metabolites could be identified as di-N-desethylamiodarone (DDEA) and 
deaminated AMI (DAA) by HPLC-MS/MS. This analytical method was then modified so 
that all metabolites could be quantified from 1mL patient plasma in the nanogram range. 
All these studies provide evidence that the metabolism of AMI is more complex than 
generally accepted: the unique formation of MDEA (scheme 3.4). Further investigations 
are needed to know whether the metabolites reported herein are synergistic to the 
therapeutic effect of the parent drug or are responsible for the undesired side effects 
observed in the AMI therapy. 
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Scheme 3.4. Metabolic pathway of amiodarone 
 
 
Another example of pharmacological studies that were performed using HPLC-ESI-
MS/MS is presented in Part 3. Taurolidine has to be found to exert a selective 
antineoplastic effect that can be used for the treatment of brain tumors. The difficulty of 
the pharmacokinetic studies was that taurolidine is not stable in aqueous solutions and 
forms an equilibrium with degradation products. A new highly selective and sensitive 
quantification method based on ESI-MS/MS was developed. With this approach, the 
pharmacokinetics of taurolidine and its degradation products taurultame and taurinamide in 
plasma and whole blood in vitro as well as in vivo could be investigated. 
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D)  Flavonoids and Plant Growth 
The comprehensive analysis in which all the metabolites of an organism are identified and 
quantified is called metabolomics (Bino et al. 2004). This new methodology contributes to 
our understanding of the complex molecular interactions in biological systems. Gas 
chromatography-MS (GC-MS), HPLC-UV(DAD)-MS, and capillary electrophoresis (CE)-
MS are the methods of choice for qualitative and quantitative metabolite profiling. An 
instantaneous snapshot of the physiology of a cell is obtained, giving a more complete 
picture of living organisms (Villas-Bôas et al. 2005). 
 
Scheme 3.5. Main steps involved in sample preparation, analysis and processing during 
metabolome analysis. 
 
The major challenge of metabolite identification is rapid, sensitive and reliable elucidation 
of structural changes. This concerns immediate inactivation of the metabolism, extraction 
of the maximum number of metabolites in their original state and quantitative amount, 
identification of a maximum number of metabolites in a single analysis, and finally, 
principal component analyses in order to highlight the components of interest (scheme 
3.5).  
The combination of HPLC with MS enables the analysis of many classes of compounds, in 
particular non-volatile and thermally unstable metabolites that display a wide variety of 
polarities and molecular masses, without any derivatization. Plant and fungal secondary 
metabolites, amino acids, nucleotides and oligosaccharides have been identified and 
quantified from data obtained from a UV(DAD) detector or from MSn experiments. 
Especially ion trap mass spectrometers with their multiple MS capabilities and sensitivity 
in full scan mode have proven to be excellent tools for this purpose.  
Flavonoids are widely distributed in plants, fulfilling many functions including yellow or 
red/blue pigmentation in flowers and protection from attack by microbes and insects 
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(Andersen et al. 2006). They are divided in three main groups: flavones, flavanones, 
catechins, and anthocyanins. 
 
Scheme 3.6. Main groups of flavonoids 
 
Flavonoids are secondary metabolites known to modulate plant growth and development. 
In the 4th research topic, we were interested in flavonols, a subgroup of flavones that are 
assumed to modify the auxin flux in the plant. Their study is complex because of the 
multiplicity and the similarity of the different molecular structures. For example, more 
than 350 derivatives evolving from a single flavonol aglycone, quercetin, have been 
described in plants, and most of this variability comes from glycosylation by one or several 
sugar moieties (Kerhoas et al. 2006). 
In wild type and transgenic or mutant Arabidopsis thaliana plants, flavonols are 
glycosylated with up to four glucose and rhamnose substituants (Stobiecki et al. 2006). The 
HPLC-UV(DAD)-ESI-MS approach is well suited for their determination, providing 
molecular weight, general structure, and relative concentrations of the various constituents 
without derivatization.  
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IV. OUTLOOK 
We plan to focus our next developments on improvements of analysis and data processing 
methods, and initiation of new research fields. 
The application of high-resolution mass spectrometry in structure elucidation of natural 
products will be established for thermal labile molecules contained in complex mixtures. 
High accurate ESI-MS and MS/MS provide data that allow only a small number of 
theoretical elemental compositions for a sample ion, in most cases just a single hit. Once 
the elemental compositions of protonated sample molecules and their fragment ions is 
known, the interpretation of the fragmentation pattern, in combination with additional 
analytical data from H/D exchange experiments, amino acid analysis and UV/VIS 
spectroscopy, should allow a simplified and unambiguous structure determination of 
unknown natural products.  
New data processing methods based on accurate masses will also allow the recognition of 
functional group in bioorganic molecules. The deviation of the exact mass compared to the 
nominal mass depends on the class of compounds and the molecular weight and was 
defined as "delta mass variation" (Juris 2006). This approach was successfully applied for 
the identification of amino acids. Functional groups of petroleum components were also 
identified by comparison of the delta mass to the theoretical exact masses in a so-called 
"Kendrick plot" allowing their classification and characterization. 
The improvement of HPLC-MS data processing using statistical tools is another ongoing 
research domain. For the growing flow of information obtained from an increasing number 
of samples, an algorithm was developed that detect the relevant component in a set of 
analyses. This so-called "principal component analysis" (PCA) software provides 
information about variance in data sets and simultaneously highlights signals (Rt-m/z pairs 
in HPLC-MS chromatograms) responsible for variation. This straightforward approach, 
particularly when complex HPLC-MS data have to be processed as e.g. in the 
characterization of polyamine derivatives found in spider venom (Chap. 5.1), or flavonoid 
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profiling as presented in chapter 5.4, will improve the detection rate of unknown natural 
products, or drug metabolites. 
The development of mass spectrometry as a platform for strategies that study non-covalent 
interactions between small organic molecules or metal ions, and receptors like e.g. 
proteins, or RNA will be followed. The method will be based on the soft ionization 
techniques MALDI and ESI. This so-called SAR (structure-activity relationship) approach 
allows the identification and optimization of high-affinity ligands (compounds that bind to 
receptors) by quantification of binding affinity, stoichiometry, and specificity over a wide 
range of ligand binding energies. A set of diverse compounds, in particular polyamine 
derivatives will be measured by ESI- or APCI-MS in order to identify those that bind to 
receptor, e.g. a strain of RNA. Competition experiments will be used to identify the ones 
that bind to the same site and those that do not, and to estimate stoichiometry and binding 
constants of the complexes. 
For example, it is planned to study the interactions between synthetic or newly identified 
natural products, e.g. polyamine derivatives that are synthesized in the laboratory of Prof. 
S. Bienz at the University of Zurich, and DNA and RNA strains. ESI- and MALDI-MS-
based methods will be used as they have been successfully employed to measure DNA or 
RNA complexes with proteins, drugs or other ligands (Beck et al. 2001; Hofstadler et al. 
2001). We hope with this approach to gain insights into the understanding of biological 
processes on a molecular level. Furthermore, this approach has a potential to allow the 
design of drugs that specifically bind selected DNA sequences in a combinatorial way. 
A recently discovered novel and special field of application for mass spectrometry is the 
taxonomy of microorganisms (Fenselau et al. 2001). Increasing numbers of highly 
halophilic (= salt-loving) microorganisms - both Archaea and Bacteria - are isolated from 
salt lakes and saline marshes in many parts of the world. These organisms, which grow 
well at NaCl concentration up to 4M, appear to play a vital ecological role in their habitats 
and show great promise for applications in environmental biotechnology. The de-
replication and ultimately the taxonomic characterization of halophilic cells from natural 
isolates, however, still remain laborious and expensive.  
In collaboration with Prof. H. Patzelt from the Sultan Qaboos University in the Sultanate 
of Oman, new methods based on MALDI-MS are currently developed for the taxonomic 
characterization of halophilic Archaea. A fingerprint comparison of whole-cell MALDI 
mass spectra would allow their rapid and facile identification.  
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V. SPECIFIC CASE STUDIES 
 
 
 
5.1. New linear polyamine derivatives in spider venoms 
 
 
 
Abstract 
Linear free polyamines were characterized in the venom of the spiders Agelenopsis aperta, 
Hololena curta, and Paracoelotes birulai by RP-HPLC coupled to mass spectrometry. The 
several linear polyamines found were tetramine, pentamine, and hexamine derivatives. 
Some of these natural products were identified as N-hydroxylated, guanidylated, or 
acetylated compounds. In addition, the biosynthetical pathway leading to the formation of 
acylpolyamines in spider venoms is discussed. 
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Introduction 
Spider venoms are known to be the source of a multitude of natural products and 
particularly of acylpolyamines (Schäfer et al. 1994; Itagaki et al. 2000; Chesnov et al. 
2002). Although many acylpolyamines with rather uncommon polyamine backbones were 
found in spider venoms, information about the presence of the respective free non-
derivatized bases is scarce in literature. Low molecular weight biogenic amines such as the 
ubiquitous putrescine (PA4)1, cadaverine (PA5), spermidine (PA34), and spermine 
(PA343) were characterized in the mygalomorph spiders Scodra griseipes (Lange et al. 
1992; Lange et al. 1992), the Sydney funnel-web spider Atrax robustus (Duffield et al. 
1979), and the species Dugesiella hentzi, Aphonopelma emilia and two further 
Aphonopelma species (Cabbiness et al. 1980). The same biogenic amines along with 
histamine were also reported in nine typical Japanese spider species (Hagiwara et al. 
1991). Caldopentamine (PA3333) was found, in addition to the more common biogenic 
amines, not in the venom but in the silk glands and in the heads of the spiders Nephila 
clavata and Araneus ventricosus (Hamana et al. 1991). Apart from this last example, no 
information about spider derived, non-acylated polyamines containing more than four N-
atoms is found in literature. The only natural sources for such extended polyamines, 
namely pentamines and hexamines, are bacteria. For example, homocaldopentamine 
(PA3334) (Oshima et al. 1983) and isomeric thermopentamine (PA3343) (Hamana et al. 
1990) were extracted from the thermophilic eubacteria Thermus thermophilus and 
homocaldohexamine (PA33334), thermohexamine (PA33343), and homothermohexamine 
(PA33433) in Bacillus schlegelii (Hamana et al. 1992). In these cases, also branched 
polyamines were characterized in addition to the linear compounds. These polyamines 
from bacteria were identified either by gas chromatography coupled to mass spectrometry 
(GC-MS) after their derivatization with heptafluorobutyric anhydride (HFBA) (Niitsu et al. 
1993), or by liquid chromatography (LC) and fluorescence detection of the o-
phthalaldehyde (OPA) reaction products (Hamana et al. 1998). 
                                                 
1 The abbreviation PA stands for polyamine; the figures designate the number of methylene in-between the 
several N-atoms Bienz, S., Detterbeck, R., Ensch, C., Guggisberg, A., Häusermann, U., Meisterhans, C., 
Wendt, B., Werner, C. and Hesse, M. (2002). "Putrescine, spermidine, spermine, and related polyamine 
alkaloids." Alkaloids 58: 83-338..  
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Recently, we have used high-performance liquid chromatography, on-line coupled with 
atmospheric-pressure chemical ionization mass spectrometry (HPLC-UV(DAD)-APCI-MS 
and MS/MS), to identify the acylpolyamine toxins contained in the venom of the spiders 
Paracoelotes birulai (Amaurobiidae) (Chesnov et al. 2000) and Agelenopsis aperta 
(Agelenidae) (Chesnov et al. 2001). This instrumental setup allowed us to detect and to 
elucidate the structure of polyamine derivatives directly, without an additional 
derivatization step. For example, a total of 38 compounds were characterized in A. aperta 
(Manov et al. 2002), and it was shown that for PA3343 and PA3334 all acylpentamine 
isomers of the type Acyl33342, Acyl3343, Acyl3433, and Acyl4333 were present in the 
toxin mixture. On the basis of this latter finding, we postulated that the biosynthetic 
precursors of the acylpolyamines in spider venom might be the parent linear polyamines 
that are ‘statistically’ mono-acylated at either terminal amino group of the molecule. To 
support these assumptions, we searched for free polyamines in the venoms of the 
aforementioned spiders P. birulai and A. aperta, as well as in Hololena curta (Agelenidae). 
Due to the absence of a chromophore on such compounds, UV detection was not 
appropriate. Reverse-phase HPLC-APCI-MS was selected as the method of choice for the 
separation and detection of linear polyamines. 
 
Experimental 
Lyophilized spider venom samples from A. aperta, H. curta, and P. birulai were purchased 
from Fauna Laboratories, Ltd. (Almaty, Kazakhstan). A portion of the crude venom (∼100 
µg) was dissolved in MeCN/H2O (3:2) containing 0.1% of trifluoroacetic acid (TFA) and 
the stock solution stored at –20°C prior to use. Chromatographic separations were 
performed with an Interchim Uptisphere RP C18 column (UP3HDO–20QS, 3 µm, 4.6x200 
mm) at a flow rate of 500 µl min–1 gradients of MeCN/H2O/0.1% TFA from 0 to 10% over 
5 min and from 10 to 15% over 10 min. The APCI-MS and MS/MS experiments were 
performed on a triple quadrupole instrument (Finnigan TSQ 700), and the base peak 
chromatograms (BPC) were obtained by monitoring the ions with m/z between 100 and 
1000. 
                                                 
2 The different acyl groups linked to the polyamine backbones were 4-OH-Benz, 2,5-(OH)2-Benz, and IndAc. 
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Results and Discussion 
The peaks observed in the chromatograms for the venom of the three spider species were 
distributed over three different regions (figure 1). The first fraction, containing the linear 
polyamines, eluted with retention times (tR) close to 5 min. The second fraction, eluting 
with tR between 10 and 12 min, was composed of pyrimidine and purine derivatives. This 
class of compounds was found in the venom of the spider Latrodectus menavodi and will 
not be further discussed here (Horni et al. 2000). The third fraction, eluting with tR 
between 12 and 15 min, consisted of acetyl- and guanidino-substituted linear polyamines. 
 
Figure 1. Reverse-phase HPLC-MS base peak chromatograms (BPC) of the venom of the spiders 
A. aperta (A), H. curta (B), and P. birulai (C) obtained with an Interchim UP3HDO–20QS column 
(4.6x200 mm, 500 µl min–1) with a MeCN/H2O/TFA gradient. An arrow indicates fractions 
containing linear polyamines and derivatives thereof. 
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The first fraction containing the polyamines is rather prominent in the venom of both 
Agelenidae species A. aperta and H. curta, but little abundant only in the venom of P. 
birulai. The mass spectra of the compounds co-eluting at tR = 5.4 min in A. aperta (tR = 5.5 
min in the case of H. curta) gave rise to the quasi-molecular ions [M + H]+ at m/z 203, 219, 
260, 276, 317, and 333. 
Fragmentation by MS/MS of the respective [M + H]+ ions and interpretation of the 
resulting daughter ions allowed the elucidation of the free polyamine structures: the series 
of [M + H]+ ions at m/z 203, 260, and 317 (the respective masses differing by 57 Da each) 
correspond to the mixtures of tetramines PA343 and PA334, the pentamines PA3343 and 
PA3334, and the hexamines PA33433, PA33343, and PA33334, respectively (Table 1). 
The structure assignments are based on the comparison of the MS/MS data of the linear 
polyamines with those of the parent acylpolyamine compounds. 
The second series of [M + H]+ ions, recorded at m/z 219, 276, and 333, were identified as 
N-hydroxylated (+16 Da) derivatives of the tetramines, pentamines, and hexamines 
mentioned above. However, according to their fragmentation patterns, not all of the 
theoretically possible isomers of the hydroxylamines are present in the venoms. The OH 
group was solely found to be connected to the secondary N-atoms linked to terminal 
aminopropyl units. The compounds characterized are PA3(OH)43 and PA3(OH)34 for [M 
+ H]+ at m/z 219, PA3(OH)343 and PA3(OH)334 for [M + H]+ at m/z 276, PA3(OH)3343 
and PA3(OH)3334 for [M + H]+ at m/z 333. To our knowledge, no free N-hydroxylated 
linear polyamines have been isolated from a natural source before. 
Concentrating on the acetyl and guanidyl derivatives, the chromatogram of the venom of 
P. birulai shows two prominent signals at tR = 12.3 and 12.9 min. The MS of the 
respective fractions reveal the presence of [M + H]+ ions at m/z 302, 318 (tR = 12.3 min) 
and at m/z 344, 359, and 401 (tR = 12.9 min) (figure 1C). 
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Table 1. Polyamines and new polyamine derivatives found in A. aperta, H. curta, and P. birulai. 
b 
Spider Trivial Namea 
tR 
[min] 
[M + H]+ 
m/z m n o R1 R2 R3 
Structure 
PA343 5.4-5.5 203 1 2 1 H – – 
PA334 5.4-5.5 203 1 1 2 H – – 
PA4(OH)33 5.4-5.5 219 2 1 1 OH – – 
PA3(OH)43 5.4-5.5 219 1 2 1 OH – – 
A. aperta 
H. curta 
PA3(OH)34 5.4-5.5 219 1 1 2 OH – – 
 
PA3343 5.4-5.5 260 2 1 – H H H 
PA3334 5.4-5.5 260 1 2 – H H H 
PA3(OH)343 5.4-5.5 276 2 1 – OH H H 
A. aperta 
H. curta 
PA3(OH)334 5.4-5.5 276 1 2 – OH H H 
PA3334Gu 12.3 302 1 2 – H H Gu 
PA3(OH)334Gu 12.3 318 1 2 – OH H Gu P. birulai 
Ac3334Gu 12.9 344 1 2 – H Ac Gu 
 
PA33433 5.4-5.5 317 2 1 1 H H H 
PA33343 5.4-5.5 317 1 2 1 H H H 
PA33334 5.4-5.5 317 1 1 2 H H H 
PA3(OH)3343 5.4-5.5 333 1 2 1 OH H H 
A. aperta 
H. curta 
PA3(OH)3334 5.4-5.5 333 1 1 2 OH H H 
PA33334Gu 12.9 359 1 1 2 H H Gu 
P. birulai Ac33334Gu 12.9 401 1 1 2 H Ac Gu 
H. curta Ac33343Ac 12.8 401 1 2 1 H Ac Ac 
 
a) PA stands for polyamine; the figures designate the numbers of methylene units in-between the several N-atoms. 
b) Abbreviations for the substituents: Ac = CH3CO; Gu = H2N–C=NH. 
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MS/MS data of the first fraction allowed the deduction of the structures PA3334Gu3 ([M + 
H]+ m/z 302) and the N-hydroxylated derivative PA3(OH)334Gu ([M + H]+ m/z 318); the 
major components of the second fraction were found to be the acetylated derivatives 
Ac3334Gu ([M + H]+ m/z 344), PA33334Gu ([M + H]+ m/z 359), and Ac33334Gu ([M + 
H]+ m/z 401).The presence of the guanidyl group at the terminus of the polyamine 
backbone was already shown to be characteristic for toxins from P. birulai (Chesnov et al. 
2000). H. curta revealed no guanidyl derivative but a bis-acetylated polyamine, 
Ac33343Ac ([M + H]+ m/z 401), eluting with tR = 12.8 min (figure 1B). Acetylated 
polyamines were previously isolated solely from bacteria, e.g. N1-acetylcaldopentamine 
(Ac3333) from Staphilothermus hellenicus (Hamana et al. 2003). 
 
Conclusion 
The linear polyamines found in the three spider species are supportive for the biosynthesis 
previously proposed for the acylpolyamines (Manov et al. 2002). The linear polyamines 
arise probably from putrescine (PA4) by enzyme catalyzed repetitive addition of 
aminopropyl units, as described in the literature for mammalian cells (Tabor et al. 1984; 
Geneste et al. 1998). Once the linear polyamines are formed, they can be regiospecifically 
hydroxylated to the N-hydroxy derivatives. Interestingly, some bis-N-hydroxylated 
acylpolyamine toxins are described for A. aperta (Chesnov et al. 2001) although no free 
linear polyamine containing two N–OH moieties could be detected in the present study. 
Finally, the linear compounds are acylated at either end of the polyamine backbone with 
one of the known aromatic carboxylic acids 4-OH-BzOH, 2,5-(OH)2-BzOH, 2,4-(OH)2-
PhAcOH, IndAcOH, 4-OH-IndAcOH, and 6-OH-IndAcOH (Schäfer et al. 1994) to yield 
the acylpolyamines. 
As already mentioned, underivatized linear free polyamines are of low abundance in the 
case of P. birulai. All of the four compounds detected for this species possess a guanidyl 
end group attached to the aminobutyl portion of the polyamine backbone. However, 
‘regular’ acylpolyamine toxins, having no guanidyl end group, are present in the venom 
cocktail of P. birulai (Chesnov et al. 2000). Elucidation of the complete biosynthetic route 
to acylpolyamines has yet to be confirmed, e.g. by in-vivo experiments. 
                                                 
3 Gu designates a terminal guanidyl group instead of a primary amine. 
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5.2. Tandem Mass Spectrometric Investigation of 
Acylpolyamines of Spider Venoms and their 15N-
Labeled Derivatives 
 
 
 
Abstract 
The fragmentation mechanism of the acylpentamine toxins 1-4 found in the venom of the 
spider Agelenopsis aperta has been investigated in detail. To identify the origin of the two 
doublets of unexpected fragment ions at m/z 129/112 and m/z 115/98, three synthetic 15N-
labeled analogs 5-7 have been prepared and subjected to CID fragmentation on a triple 
quadrupole mass spectrometer. It appears that the unexpected doublet of fragment ions 
arises from an internal portion of the polyamine backbone after either a transaminative Zip 
reaction or a sequential fragmentation of the quasi-molecular ion. In-source CID 
experiments support the second alternative as more likely. The detailed knowledge of 
acylpentamine fragmentation mechanisms is essential for the correct characterization of 
isomeric compounds, particularly for co-eluting compounds within complex mixtures such 
as spider venoms. 
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Introduction 
Polyamines and polyamine-containing alkaloids are widely found throughout the plant and 
animal kingdom (Schäfer et al. 1994; Bienz et al. 2002). Over the past decades, spider 
venoms, particularly those fractions containing acylpolyamine derivatives (Schäfer et al. 
1994; Itagaki et al. 2000; Chesnov et al. 2002), have increasingly attracted the attention of 
scientists. With the advent of more sensitive and selective analytical methods — in 
particular of the modern mass spectrometric approaches — not only the major but also 
minor constituents of such trace toxin sources have become amenable to detection and 
structural elucidation. Recently, we demonstrated with the re-investigation of the venom of 
the spider Agelenopsis aperta (Agelenidae) that this toxin cocktail contains, in addition to 
the previously found 11 major acylpolyamines, 27 further minor components that evaded 
earlier investigations (Chesnov et al. 2001; Manov et al. 2002). 
The detection and structural elucidation of these spider toxins relied particularly on the on-
line coupled high-performance liquid chromatography, UV diode array detection, and 
atmospheric-pressure chemical ionization mass spectrometry (HPLC-UV(DAD)-APCI-MS 
and -MS/MS). This arrangement allowed the efficient separation and investigation of the 
several venom components, making most economical use of the precious sample material. 
The structural elucidations, however, would not have been possible if a profound 
knowledge of the fragmentation behavior of the parent class of compounds had not been 
available, especially in the case of co-eluting isomers. Although most of the toxins of A. 
aperta were disclosed on the basis of pure ‘MS investigations’ by comparison of 
fragmentation patterns observed and explained during previous investigations, five of them 
were only revealed by their comparison with synthetic material (Manov et al. 2002). Also 
in these cases, their identity could only be revealed due to the specific fragmentation 
behavior of the several structural isomers that could only be studied with the pure sample 
compounds. On the whole, the knowledge of the fragmentation patterns of polyamines and 
also the deeper understanding of the respective fragmentation mechanisms, proved an 
important prerequisite to allow efficient and definitive identification and characterization 
of known and new polyamine derivatives by MS methods. 
In the course of our investigation of the venom of A. aperta, we have intensively studied 
the fragmentation behavior of acylpolyamines and have also discussed possible 
fragmentation paths and mechanisms (Chesnov et al. 2001). For some groups of isomeric 
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acylpentamines, however, inconsistencies with regard to expected fragmentation patterns 
surfaced. Fragments of the types a and b are formed upon collision induced dissociation 
(CID) by intramolecular nucleophilic substitutions (SNi) according to Scheme 1. 
Concentrating solely on the proposed fragmentation reaction for the ‘loss of the terminal 
diaminopolymethylene unit, they were thought to be indicative for the identification of the 
terminal diamine portions of the toxins. However, the loss of these diamines as marker is 
only true with reservation. For instance, the toxins IndAc43331 (1) and IndAc3433 (2) 
would be expected to give rise to fragments a332 (m/z 115) and b33 (m/z 98) and not to 
fragments a43/a34 (m/z 129) and b43 (m/z 112), while isomeric IndAc3343 (3) and 
IndAc3334 (4) should produce fragments a43/a34 and b43 instead, and none of the 
fragments a33 and b33. 
Scheme 1. Mass spectral fragmentation of the terminal part of the [M + H]+ ions of the IndAc 
pentamine derivatives 1-4.  
 
                                                 
1 The expression IndAc4333 stands for a linear pentamine possessing 4, 3, 3, and 3 methylene units in-
between the several N-atoms, whereby the IndAc group is located at the N-atom which is followed by the 
tetramethylene unit. IndAc is the abbreviation for 1H-indole-3-acetyl. 
2 The subscripts denote the number of methylene groups contained in the two chains or rings. 
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In reality, however, the CID spectra deriving from the two quasi-molecular ions of 
synthetic IndAc4333 and IndAc3433 showed also signals at m/z 129 and 112, which should 
be indicative for a terminal PA34 or PA43 unit3, and in the case of IndAc3334 (but not of 
IndAc3343!), signals at m/z 115 and 98 were additionally found, which would imply a 
PA33 end-portion for the molecule (figure 1). 
The feature of exhibiting unexpected signals of such types is not specific to pentamines 
bearing the IndAc moiety; it is also characteristic for other pentamine derivatives that bear, 
e.g., a 4-hydroxybenzoic or a 2,5-dihydroxybenzoic group in place of IndAc. 
 
Figure 1. ESI-MS/MS of the [M + H]+ ion at m/z 417 of (A) IndAc3334 (1), (B) IndAc3343 (2), 
(C) IndAc3433 (3), and (D) IndAc4333 (4). Unexpected fragment ions are indicated by an arrow. 
                                                
3 PA34 stands for a linear triamine with 3 and 4 methylene units (in this succession) in-between the terminal 
and internal N-atoms (Bienz et al. 2002). The nomenclature is also used for more extended polyamines. 
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As an explanation for the peculiar MS behavior of the acylpentamines, we offer two 
plausible reaction paths involving an acid promoted transamidative (A) or transaminative 
(B) Zip reaction (Kramer et al. 1977), as outlined in Scheme 2 in the case of IndAc3334 
(4). For both transformations, precedence is available in the MS literature: transamidation 
reactions were discussed with respect to the MS behavior of 4-hydroxycinnamoyl 
spermidines (Hu et al. 1996) as well as N,N’-bis(4-hydroxycinnamoyl) spermidines (Bigler 
et al. 1996), and transamination reactions were considered for polypropylenamine 
dendrimers (De Maaijer-Gielbert et al. 1999) and for monoimidazole polyamine conjugates 
(Zhu et al. 2002). The presence of the signal doublet at m/z 129/112 in the CID of 
IndAc4333 would rather support the transamidative pathway A, whereas the lack of signals 
at m/z 115/98 for IndAc3343 would suggest pathway B proceeding through 
transaminations. 
Scheme 2. Possible gas phase rearrangements of the [M + H]+ ions of IndAc3334 (4). 
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To distinguish between these two paths, we have synthesized the three 15N-containing 
IndAc3334 derivatives IndAc15N3334 (5), IndAc315N334 (6), and IndAc3315N34 (7) 
(Manov et al.) (figure 2). The three labeled isomers were then analyzed by ESI-MS/MS, 
analogously to the unlabeled parent compound. The results of this MS investigation are 
presented below. 
 
 
Figure 2. Investigated 15N-labeled IndAc3334 derivatives 5-7. 
 
 
 
 
 
 
Experimental 
Material 
All 15N-labeled acylpolyamine samples used were synthesized in our laboratory (Manov et 
al. 2004). For ESI-MS, all compounds were dissolved in a 1:1 mixture of HPLC grade 
MeOH (Scharlau, Barcelona, Spain) and H2O (purified with a Milli-QRG apparatus, 
Millipore, Milford, MA) at a concentration of 50 nmol ml–1. 
Mass Spectrometry 
ESI tandem mass spectra were recorded with a TSQ 700 triple quadrupole mass 
spectrometer (Finnigan MAT, San Jose, CA) equipped with a combined Atmospheric 
Pressure Ion (API) source. Samples were continuously introduced into the source with a 
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Syringe Pump 22 (Harvard Apparatus, Holliston, MA) at a flow rate of 5 µl min–1. The 
ESI operating conditions in positive mode were: capillary voltage 4500 V; heated capillary 
temperature 210°C; sheath gas N2 with an inlet pressure of 30 psi; electron multiplier: 
1000 V; conversion dynode: –15 kV; resolution: 0.7 Da at half peak height; scan rate: 900 
Da s–1; 16 scans were averaged. For the CID experiments, Ar was used as the collision gas 
with a relative pressure of 2.5–3.3 mtorr. The collision-induced dissociation offset (Coff) 
was set to –27 V and the electron multiplier was set to 1500 V. In-source CID spectrum 
was obtained by setting the octopole voltage at –3 V, and fragment ions were further 
subjected to CID by setting the Coff voltage at –22 V. 
 
 
 
 
Results and Discussion 
The ESI-MS/MS of the three labeled compounds 5–7 and of the unlabeled parent 
compound 4 — all obtained under the same conditions from the respective [M + H]+ 
parent ions — are shown in figure 3. Concentrating on the signals of type a and b, it is 
readily recognized that the signals for the respective fragment ions a34/b434 at m/z 129/112 
remained unaffected for all the 15N-containing compounds. However, the signals for the 
a33/b33 ions were recorded only for IndAc15N3334 (5) and IndAc315N334 (6) at m/z 
115/98. For IndAc3315N34 (7) the masses were higher by 1 Da (m/z 116/99) and 
consequently designated as 15N-a33 and 15N-b33 respectively. 
                                                 
4 The fragment ion at m/z 130 has been previously described as 3-methylene-3H-indolium (C9H8N+) 
(Chesnov et al. 2001) and is not considered as labeled 15N-a43/a34. 
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Figure 3. ESI-MS/MS of the [M + H]+ ions at m/z 417 of (a) IndAc4333 (4), and at m/z 418 of 
labeled (b) IndAc15N3334 (5), (c) IndAc315N334 (6), and (d) IndAc3315N34 (7). 15N-label 
containing a and b fragment ions are indicated by an arrow. 
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These results unambiguously show that the central portion of the polyamine moiety (as 
indicated by the surrounded part of the compound in figure 4) is incorporated in the 
fragments a33/b33 deriving from 4. Therefore, the transamidative pathway A for the 
formation of these fragments is certainly not operative and can be excluded. Otherwise, 
doublets for labeled fragments a33/b33 at m/z 116/98 or 116/99 should have been found for 
isomers 5 and 6, respectively. On the other hand, the doublet of signals at m/z 116/99 for 
the 15N-containing fragments a33/b33 deriving from isomer 7 is supportive for the 
transaminative pathway B. 
 
Figure 4. Portion of the polyamine backbone of IndAc3334 responsible for the formation of the 
fragment ions a33/b33 at m/z 115/98. 
 
An alternative fragmentation path that was not seriously considered initially, but is also 
consistent with the experimental data, is the sequential fragmentation of acylpolyamines 
involving loss of a terminal aminoalkyl group in a first stage, forming e.g. for IndAc3334 
the ion [IndAc333 + H]+. Such a secondary parent ion could subsequently be fragmented 
according to the general rules (Scheme 3), and lead to fragments a33 and b33. These 
fragment ions consist of the same portions of the parent molecule as those explained with 
the transamination/fragmentation pathway. However, if IndAc3334 dissociates by the usual 
SNi reaction by attack of the terminal amino group at the CH2 group in α-position to the 
protonated secondary N-atom, protonated pyrrolidine (see fragment ions at m/z 72 in figure 
3) and neutral IndAc333 is formed. Thus, the observed [IndAc3315N3 + H]+ at m/z 347 
from IndAc3315N34 (7) cannot directly derive from this SNi reaction. In order to retain the 
charge on the IndAc-end, a proton transfer process has to be operative. It is possible that a 
proton-bound complex is formed during fragmentation, where the IndAc333-unit and 
pyrrolidine compete for the H+. This mechanism was postulated to explain the formation of 
the bn/yn ion series in the case of peptide fragmentation (Polce et al. 2000). 
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Scheme 3. Sequential mass spectral fragmentation of the [M + H]+ ions of IndAc3315N34 (7). 
 
Support for the sequential fragmentation of 4–7 is found with the signals at m/z 346 and 
347, corresponding to the proposed ions [IndAc333 + H]+ (figure 3). That these ions are 
formed rather easily is also demonstrated with the in-source CID experiment, which 
involves very mild energy transfer and thus very mild fragmentation conditions, performed 
with IndAc3315N34 (7) (figure 5). By in-source CID, almost exclusively the respective ions 
[IndAc3315N3 + H]+ registered at m/z 347 were formed. These ions, selected by the first 
quadrupole and subjected to the usual CID by collision with Ar in the collision cell, gave 
rise to a spectrum that exhibited, not surprisingly, signals at m/z 116 and 99 for the 15N-
labeled fragments of type a33 and b33. 
 
Figure 5. In-source CID of the [M + H]+ ion at m/z 418 of labeled (a) IndAc3315N34 (7), and (b) 
MS/MS of the secondary parent [IndAc3315N3 + H]+ ion at m/z 347. 
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Based on the experimental data acquired by the above experiments, both mechanisms — 
decomposition of [IndAc3334 + H]+ through transamination/fragmentation (pathway B) or 
by sequential fragmentation via intermediary [IndAc333 + H]+-ions — are feasible to 
explain to the formation of fragments a34/b34 detected at m/z 129/115 in the ESI-MS/MS 
of compound 4. The fact that [IndAc333 + H]+ is formed quite easily by in-source CID and 
that this ion is also detected in the regular CID spectra talks in favor of the sequential 
fragmentation path. 
The behaviors of IndAc3433 (2) and IndAc3343 (3) are consistent with the two 
fragmentation paths discussed above as well. In the case of IndAc3433 (2), both loss of 
azetidine or transamination would form intermediates that could give rise to fragments a43 
and b43 and thus to the observed signals at m/z 129/112 (see figure 1B). In this case, the 
signal for the secondary parent ion [IndAc343 + H]+ (m/z 360) proposed for the stepwise 
pathway is not found in the spectrum, which is possibly due to the fact that this ion should 
decompose immediately after its formation to fragment a43 — and subsequently b43 — 
through a favored five-membered transition structure as described above. For IndAc3343 
(3), the doublet at m/z 129/112 can be the response to the fragments a43/a34 and b34 
deriving either by direct substitutive fragmentation or by the more complex pathways 
discussed above (see figure 1C). A doublet at m/z 115/98 for a33 and b33 is not observed 
for this compound, however, because [IndAc33 + H]+ (m/z 289), obtained by loss of 
terminal diaminoalkyl group, cannot undergo fragmentation to these ions similarly to a free 
triamine. 
In the case of IndAc4333 (1), the explanation for the formation of the ions of type a43/a34 
and b43 (see figure 1A) is slightly different: loss of any portion of the molecule from the 
amino terminus of the compound and also transaminations would never lead to an 
intermediary species that could form these fragments. However, loss of the acyl group and 
liberation of the protonated polyamine itself seems to be a favorable CID-reaction for 
Acyl4 derivatives (Manov et al. 2002). The respective signal for [PA4333 + H]+ is in fact 
found at m/z 260 in the ESI-MS/MS of IndAc4333 (1), and decomposition of the free 
polyamine can give rise to the fragments a43/a34 and b43. The corresponding [PA4333 + 
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H]+ and [PA3433 + H]+ signals for compounds 2–4 are of low abundance only or not 
observed at all (see figure 1A-D). 
For Acyl3 derivatives, the alternative formation of 4H-5,6-dihydro-1,3-oxazine species, 
represented in the spectra by the strong signals at m/z 215, is the dominant reaction of the 
head portion (Manov et al. 2002). 
 
 
Conclusion 
We have shown that acylpolyamines can form some fragments in ESI-MS/MS that are 
composed of internal portions of the polyamine moieties of the sample molecules. From a 
mechanistic point of view, a fragmentation path involving a transamidation was excluded. 
Two alternative mechanisms — by transamination followed by fragmentation, or by two 
subsequent fragmentations — are possible and cannot be distinguished. Signals of such 
fragments could lead to misinterpretations if they were regarded to be derived from the 
end-portion of the compounds. Thus, for the definite characterization and structural 
identification of acylpolyamines — particularly those natural products of low abundance 
that lack synthetic references —, such fragments are of little relevance. Of more relevance 
is the overall fragmentation pattern of the samples, which is dominated by the presence and 
location of 1,4-diaminobutane subunits. Such subunits allow some specific and 
predominant fragmentation reactions, occurring via five-membered transition structures. 
To deduce a specific sample structure on the basis of MS behavior, it is consequently 
necessary to judge the overall behavior of the considered compounds. In certain cases, the 
structural deduction might even not be feasible directly without the possibility to compare 
the sample compound with authentic samples. 
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5.3. Pharmacokinetics of Taurolidine following Repetitive 
Intravenous Infusions Measured by HPLC-MS/MS of 
the Derivatives Taurultame and Taurinamide in 
Glioblastoma Patients 
 
 
 
 
Abstract 
 
Background: Taurolidine has a known antimicrobial activity. Furthermore, at lower 
concentrations, it has been found to exert a selective anti-neoplastic effect in vitro and in 
vivo. The aim of this study was to investigate the pharmacokinetics of taurolidine in vivo 
following repetitive intravenous infusion in a schedule used for the treatment of 
glioblastoma. As a prerequisite the pharmacokinetics of taurolidine in human blood plasma 
and whole blood in vitro was investigated. 
Patients and Methods: The pharmacokinetics of taurolidine and its derivatives taurultame 
and taurinamide was investigated in human blood plasma and in whole blood in vitro using 
blood of a healthy male volunteer. During repetitive intravenous infusion therapy with 
taurolidine, plasma samples were taken every hour for a period of 13 hours per day in 
seven patients (3 male, 4 female, mean age: 48.4 ± 12.8 years, range: 27-66 years) with a 
glioblastoma. The concentrations of taurultame and taurinamide were determined using a 
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new method based on high-performance-liquid-chromatography (HPLC) online coupled to 
electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS). The taurolidine 
concentration was below the level of detection due to rapid conversion, and was back-
calculated from the taurultame and taurinamide values. After dansyl derivatization, the 
samples were analyzed by HPLC-ESI-MS/MS in the “multiple reaction monitoring” mode. 
Results: The new HPLC-ESI-MS/MS method demonstrated a high accuracy and 
reproducibility. In blood plasma in vitro, concentrations of taurultame and taurinamide 
remained constant over the incubation period. In whole blood in vitro, a time-dependent 
formation of taurinamide was observed. At the start of the incubation, the taurultame-
taurinamide-ratio was 0.95 at an initial taurolidine concentration of 50 µg/mL, and 1.69 at 
100 µg/mL. The concentration of taurultame decreased at the same rate as the taurinamide 
concentration increased, showing a logarithmic kinetics. The calculated taurolidine 
concentration remained largely constant over the 6 hour incubation period. During 
repetitive infusions in patients, calculated serum concentrations of taurolidine showed a 
strong increase after the start of each infusion and continued to increase until the end of 
infusion, followed by a rapid decline. The taurultame-taurinamide-ratio was found to 
fluctuate between 0.1 and 0.3 depending on the relation to the previous or next infusion. 
The volume of distribution was markedly higher for taurolidine, taurultame and 
taurinamide than the plasma volume. 
Discussion and conclusions: Taurolidine displayed a stable pattern of derivatives in blood 
plasma in vitro, whereas in whole blood a time- and concentration-dependent conversion 
was apparent. In patients, the calculated average taurolidine plasma concentration, 
achieved with the repetitive infusion regimen, was in the anti-neoplastic effective 
concentration range. The tissue concentrations of taurolidine and taurultame are expected 
to be higher than the plasma concentrations, taking into account the calculated volumes of 
distribution. Repetitive infusion of taurolidine is the therapeutically adequate mode of 
administration for the indication of glioblastoma multiforme. 
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Background 
The synthetic agent taurolidine (bis-(1,1-dioxoperhydro-1,2,4-thiadiazinyl-4)methane) 
(Taurolin,Geistlich Pharma, Wolhusen, Switzerland), a derivative of the non-essential 
aminoethyl-sulfonic acid taurine, has a known anti-microbial (Browne et al. 1977; Browne 
et al. 1978; Moser et al. 1978; Marti et al. 1980; Browne 1981; Knight et al. 1983; Wesch 
et al. 1983; McCartney et al. 1988; Bieselt 1997; Jurewitsch et al. 1998) and anti-endotoxin 
(Blenkharn 1987; Bedrosian et al. 1991; Watson et al. 1995) activity. Furthermore, 
taurolidine has been found to reduce the severity of peritoneal adhesions following 
abdominal surgery (Leaper 1985; Treutner et al. 1995). To exploit these effects, taurolidine 
was given systemically as an adjunct to treat severe infections and has been administered 
locally to prevent catheter infection (Jurewitsch et al. 2005), to treat pleural empyema 
(Bieselt 1997), to reduce postoperative adhesions (Leaper 1985) and to treat peritonitis 
(Browne et al. 1978; Moser et al. 1978; Blenkharn 1987).  
Recently, a taurolidine dose far below the anti-microbial effective has been found to exert 
a direct and selective anti-neoplastic effect on tumor cells derived from the brain 
(Calabresi et al. 2001; Stendel et al. 2001; Stendel et al. 2002; Stendel et al. 2002; Rodak et 
al. 2005) and gastrointestinal tract (Calabresi et al. 2001). This anti-neoplastic effect was 
based the induction of mostly caspase-independent programmed cell death by the 
synergism with Fas-ligand (Stendel et al. 2003), the generation of reactive oxygen species 
(Rodak et al. 2005) concomitant with a change in mitochondrial membrane potential and 
the release of AIF (apoptosis-inducing factor) and the suppression of VEGF (vascular-
endothelial-growth-factor) (Rodak et al. 2005). Furthermore, taurolidine exhibits anti-
neoplastic activity in patients with glioblastoma (Stendel et al. 2004; Stendel et al. 2004) 
and other tumors (McCourt et al. 2000). For glioblastoma treatment, taurolidine has been 
administered by repetitive infusions (four infusions a day lasting for 2 hours each with an 
interval of 1 hour)  (Stendel et al. 2002; Stendel et al. 2004). 
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In aqueous solution, taurolidine forms an equilibrium with taurultame and N-
hydroxymethyl-taurultame (figure 1) with taurinamide being a downstream derivative 
(Knight et al. 1981; Erb et al. 1983; Waser et al. 1985). This equilibrium has been reported 
to bee mainly on the site of taurultame and N-hydroxymethyl-taurultame so that 
taurolidine is estimated to exist in very low concentrations in aqueous solution (Erb et al. 
1982). Using pre-column derivatization and HPLC with fluorescence detection (Woolfson 
et al. 1989), a conversion of taurolidine with subsequent formation of taurinamide has been 
described following incubation of taurolidine in plasma (Jones et al. 1990). In order to 
substantiate these early findings and extend them to whole blood, experiments were carried 
out on the formation of the taurolidine derivatives in vitro using a newly developed 
quantification method. The knowledge of the pharmacokinetic behavior of taurolidine, 
taurultame and taurinamide following repetitive intravenous administration in humans is 
very limited (Vankemmel et al. 1982; Erb et al. 1983). Therefore the aim of the present 
study was to investigate the pharmacokinetics of taurolidine, taurultame and taurinamide in 
plasma and whole blood in vitro as well as in vivo following repetitive intravenous 
infusion in glioblastoma patients. For these analyses a new, highly sensitive quantification 
method was developed based on the combination of HPLC and tandem mass spectrometry 
(HPLC-ESI-MS/MS). 
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Scheme 1. Simplified representation of the formation of the derivatives of taurolidine. 
 
 
 
 
Patients and Methods 
 
Patients 
The pharmacokinetics of taurolidine in whole blood and plasma in vitro was investigated 
using blood of a healthy male volunteer (R.S.). 
Plasma samples were drawn from 7 patients (3 male, 4 female, mean age: 48.4 ± 12.8 
years, range: 27-66 years) with a glioblastoma. The patients received 4 daily infusions of a 
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2% taurolidine solution (provided by Geistlich Pharma AG, 6110 Wolhusen, Switzerland) 
with a volume of 250 mL, each administered over two hours with one hour interval 
between infusions (Stendel et al. 2004). The total daily dose was 20 g taurolidine. The 
investigations were performed as part of a study approved by the institutional ethics 
committee. All patients gave written consent to blood sampling and analysis. In 3 patients 
on two different days with one week interval and the arithmetic means of the 
corresponding values were used for the calculations. In 4 patients, samples were drawn on 
one therapy day only since the patients refused further taking of blood samples. The same 
dosing schedule regimen was used in all patients. 
The renal and liver function was within normal limits in all patients at baseline conditions: 
AST (aspartate amino transferase): 18.6 ± 9.2 U/l, range: 8.0–33 U/l; ALT (alanine amino 
transferase): 25.0 ± 10.1, range: 13–40 U/l; GGT (gamma glutamyl transferase): 25.7 ± 
10.7 U/l; 14–35 U/l; total protein: 65.0 ± 3.61 g/l, range: 60.0–70.0 g/l; creatinine: 80.4 ± 
16.4 µmol/l, range: 57.0–98.0 µmol/l; urea: 4.9 ± 1.8 mmol/l, range: 2.9–6.0 mmol/l. 
Altogether, the following drugs were used as concomitant treatment: phenytoin, 
lamotrigine, clonazepam, valproic acid, diazepam, gabapentine, oxacarbazepine, captopril, 
metoprolol, ranitidine, pantoprazole, sertraline, dexamethasone. Five patients have 
received enzyme inducing anti-epileptic drugs (phenytoin, oxacarbazepine, clonazepam, 
diazepam, valproic acid), whereas two had not. There were no statistically significant 
differences of the plasma concentrations of taurultame and taurinamide between these two 
groups (t-test; p>0.05). 
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Methods 
Determination of taurultame and taurinamide and calculation of taurolidine 
concentration 
Taurolidine as well as taurultame were not stable under electrospray-ionization-mass 
spectrometry (ESI-MS) conditions (H2O/CH3CN + 0.05% HCOOH). Therefore, a new 
sensitive method for the quantification of taurultame and taurinamide has been developed. 
After dansyl derivatization according to Knight et al. (Knight et al. 1981), the samples 
were analyzed by HPLC-ESI-MS/MS in the “multiple reaction monitoring” (MRM) mode. 
This selective and sensitive approach allowed the calculation of taurolidine concentrations 
from the taurultame and taurinamide values in one run.  
The concentrations of taurolidine were calculated as the sum of the taurultame 
quantification and the taurinamide using the following equation: Taurolidine concentration 
was calculated using the values of taurultame and taurinamide determined and the 
following equation:  
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where CTAU= taurolidine concentration [µg/mL], CTTM = taurultame concentration [µg/mL], 
CTAA = taurinamide concentration [µg/mL], MWTAU = molecular weight of taurolidine (= 
284), MWTTM = molecular weight of taurultame (= 136), MWTAA = molecular weight of 
taurinamide (= 124). 
Whole blood samples were taken using citrate tubes (Vacutainer™; Becton Dickinson, 
Heidelberg, Germany; containing 0.109M Natriumcitrat-solution 3.2%). These were then 
centrifuged for 10 min at 4°C and 3000 rpm (Eppendorf) to generate plasma samples for 
analysis. In order to be in the quantification range of the HPLC-MS method, the plasma 
samples were diluted with control human plasma depending on the expected concentration 
as follows (ex vivo samples: dilution factor 2, 5 or 10 and in vitro samples: dilution factor 
10). 
Experimentally, a total of 5 mL CH3CN were added to 1 mL plasma sample and the 
mixture was shaken for 10 min at 300 rpm. After centrifugation for 10 min at 4°C and 
3000 rpm (Eppendorf), the supernatant was decanted into a new tube and reduced in 
volume to approx. 2 mL under a stream of N2 (45 min, 45°C). Derivatization was 
performed by addition of 1 mg of dansyl chloride dissolved in 3 mL CH3CN. After shaking 
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for 10 min at 250 rpm and storage for 30 min at room temperature, 4 mL of 
dichloromethane were added and the tubes were shaken for further 10 min at 4°C with 300 
rpm. After centrifugation (10 min at 4°C and 3000 rpm), the organic layer was transferred 
to a new tube and evaporated to dryness under a gentle stream of N2 (40 min, 45°C). The 
residue was finally reconstituted in 0.5 mL CH3CN and 5 µl were injected for HPLC-
MS/MS analysis. 
HPLC analyses were performed on an Agilent 1100 system (Agilent Technologies, Palo 
Alto, CA, U.S.A.) equipped with a binary pump, and fitted with a HTS PAL autosampler 
(CTC Analytics, Zwingen, Switzerland). Chromatographic conditions: Waters Symmetry 
C18 column (100-5 150 x 2.1mm); flow rate 200 µl/min; mobile phase: linear gradient 
within 4 min from 10 to 65% of solvent B, then isocratic at 65% of solvent B for another 4 
min (solvent A: 0.05% HCOOH soln. in H2O; solvent B: 0.05% HCOOH soln. in CH3CN). 
The ESI-MS experiments in the MRM-mode were performed on a Bruker ESQUIRE-LC 
quadrupole ion trap instrument (Bruker Daltonik GmbH, Bremen, Germany), equipped 
with a combined Agilent Atmospheric Pressure Ion source (Agilent Technologies, Palo 
Alto, CA, U.S.A.). The HPLC output was directly interfaced to the ESI ion source. The 
MS-conditions were: Nebulizer gas (N2) 40 psi, dry gas (N2) 9 l/min, dry temperature 
300°C, HV capillary -4500 V, HV EndPlate offset –913 V, capillary exit 104 V, skimmer1 
30 V, and trap drive 35. The MS/MS acquisitions were performed at normal resolution 
(0.6 u at half peak height), under ion charge control (ICC) conditions (10'000).  
 
Figure 1. HPLC-ESI-MS of spiked human plasma containing 100 µg/mL taurolidine illustrating 
the selectivity of the method used for the quantification of taurinamide and taurultame 
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For taurinamide (Rt. 6.3 min) the MS/MS reaction from [M+H]+ = m/z 358 to fragment 
ions m/z 170 (scan range m/z 160 – 180) was recorded and for taurultame (Rt. 7.7 min) 
from [M+H]+ = m/z 370 to m/z 289 (scan range m/z 280 – 300). Extracted ion 
chromatograms were integrated for quantification (taurinamide: m/z 170, taurultame: m/z 
289; figure 1). Calibration standards (n = 7) in the range from 0.2 – 20 µg/mL were 
prepared by diluting appropriate volumes (< 5% of plasma volume) of aqueous taurultame 
or taurinamide solutions in blank human plasma. The standards were aliquoted and deep-
frozen.  
Plotting the peak area versus the amount of each analyte generated calibration curves 
(figure 2). 
 
Figure 2. Calibration curves for the determination of taurinamide and taurultame in human blood 
serum in the range from 0.2–20 µg/mL. The relationship is linear. The sample volumes were 200 µl 
for the measurement in aqueous solution and 310 µl for the measurement in human plasma due to 
addition of the reagents for the precipitation of protein. These differences account for the slightly 
different courses of the curves. For details see Methods. 
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Validity of the detection of taurultame and taurinamide by HPLC-MS 
The precision and accuracy of the method was evaluated by analysis of two replicates of 
human plasma samples spiked with taurinamide or taurultame at three different 
concentrations (0.2, 2.0 and 20 µg/mL) in two separate runs. The HPLC-MS method was 
able to detect taurultame with an accuracy of 5-9 % and taurinamide with an accuracy of 1-
2 % in the concentration range of 2-20 µg/mL. The variation coefficient was 9.1 ± 0.8 % 
for taurultame and 4.8 ± 2.1 % for taurinamide in the concentration range of 0.2-20 µg/mL 
(table 1, figure 2). 
 
Table 1. Precision and accuracy of the HPLC-MS method 
 nominal concentration 
 (µg/mL) 
CV between-batch 
(%) n = 4 
ACC between-batch 
(%) n = 4 
taurinamide 0.2 5.6 86 
 2.0 2.4 98 
 20.0 6.5 101 
    
taurultame 0.2 10.0 86 
 2.0 8.4 95 
 20.0 9.0 109 
AAC = coefficient of variation as a measure of dispersion of a probability distribution 
AAC = accuracy in % of the nominal concentration 
 
 
Stability of taurolidine, taurultame and taurinamide in plasma 
Whole blood (80 mL) was collected from a healthy male volunteer (R.S.) using citrate 
tubes (Vacutainer™; Becton Dickinson, Heidelberg, Germany; containing 0.109M 
Natriumcitrat-solution 3.2%). These were then centrifuged at 3000 rpm for 10 minutes 
(Eppendorf) for plasma extraction. Then 100 µg/mL of taurolidine were added to the 
plasma, followed by incubation at 37°C for 0, 5, 10, 20, 30, 60, 120, 240 or 360 min. All 
samples were immediately frozen and stored at -80 °C until analysis. The subsequent 
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sample preparation and analysis were performed as described in the section 
“Determination of taurultame and taurinamide and calculation of taurolidine 
concentration”. 
 
Stability of taurolidine, taurultame and taurinamide in whole blood 
Whole blood (80 mL) was taken from a healthy male volunteer (R.S.). Then 50 or 100 
µg/mL of taurolidine were added, followed by incubation at 37°C for 0, 5, 10, 20, 30, 60, 
120, 240 or 360 min. The samples were collected using citrate tubes (Vacutainer™; Becton 
Dickinson, Heidelberg, Germany; containing 0.109M Natriumcitrat-solution 3.2%). These 
were centrifuged at 3000 rpm for 10 minutes (Eppendorf) for plasma extraction and 
immediately frozen and stored at -80 °C until analysis. Further sample preparation and 
analysis were performed using the method described in the section “Determination of 
taurultame and taurinamide and calculation of taurolidine concentration”. 
 
Extraction of plasma samples of the patients and detection of taurultame and 
taurinamide 
Whole blood (6 mL) was collected every 60 minutes starting immediately before the first 
taurolidine infusion (8:00 a.m.) from each patient using citrate tubes (Vacutainer™; 
Becton Dickinson, Heidelberg, Germany; containing 0.109M Natriumcitrat-solution 
3.2%). These were then centrifuged within 20 minutes of collection (Eppendorf, 3000 rpm, 
10 min) and the supernatant of 2-4 mL frozen and stored at -80 °C until analysis. Further 
sample preparation and analysis were performed using the method described in the section 
“Determination of taurolidine”. 
 
Pharmacokinetic parameters 
During steady-state-conditions the same amount of a substance is taken in and eliminated 
per period of time. This can only be achieved by a continuous infusion. As an 
approximation, repetitive infusions can be regarded as a continuous infusion which is 
“cutted into pieces” (Notari 1987). Then, an approximation of a steady-state-condition in 
kind of figures is reached after 5-6 half-life-periods (Notari 1987; Canal et al. 1998). This 
corresponds to the time period from 8.5-10.2 hours in the present study. Correspondingly, 
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analysis of the present data had shown that following the fourth infusion an approximation 
of a steady-state-condition has loomed. Probably the steady-state would have achieved 
after an additional fifth infusion. Taking into account these short-comings resulting from 
the data available, we tried to estimate pharmacokinetic parameters using an 
approximation of a steady-state-condition without assuming a compartment model.  
A steady state was assumed for an interval of 4 hours comprising hours 9 through 12 
following the start of infusion. The lowest (Cmin (9-12 h)) and highest (Cmax (9-12 h)) 
concentrations of taurolidine, taurultame and taurinamide, respectively during this interval 
were extracted from the individual concentration-time curves. The area under the curve 
during this interval was calculated using the trapezoidal rule. The mean concentrations 
were calculated according to the formula 
ervalintstatesteadyapprox
AUC
C hhav −−
= −− .
)129(
)129(  
where Cav (9-12 h) = average concentration of taurolidine, taurultame and taurinamide, 
respectively [µg/mL]; )129( hAUC − = area under the curve during the approximated steady-
state [µg·h/mL]; and approx. steady-state-interval = investigated 4-hour interval from hour 
9 to 12 with approximated steady-state-conditions. 
Peak trough flow fluctuation was calculated as 
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Where PTF(9-12h) = peak trough flow fluctuation [%]; Cmax (9-12 h) = maximal concentration 
of taurolidine, taurultame an taurinamide, respectively during the approximated steady-
state-interval investigated [µg/mL]; and Cmin (9-12 h) = minimal concentration of taurolidine, 
taurultame an taurinamide, respectively during the approximated steady-state-interval 
investigated [µg/mL].  
The volume of distribution under steady-state conditions was calculated according to the 
formula 
12h)-max(9
hD C
isteredminaddosetotalV =− )129(  
where VD(9-12h) = volume of distribution during the approximated steady-state-interval 
investigated [l]; total dose administered = total dose administered per day; and Cmax(9-12h) = 
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highest concentration of taurolidine, taurultame and taurinamide, respectively, during the 
approximated steady-state-interval investigated [µg/mL].  
Clearance under the approximated steady-state-conditions was calculated according to the 
following formula: 
)129(
)129(
h
h AUC
isteredminaddosetotalCl
−
− =  
where Cl(9-12h) = clearance under the approximated steady-state-conditions [l/h]; total dose 
administered = total dose administered per day; and AUC(9-12h) = area under the curve 
during the approximated steady-state-conditions [µg·h/mL]. 
The plasma half-life during the approximated steady-state-interval investigated was 
calculated as  
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1 h
t
−
 = plasma half-life during the approximated steady-state-interval [h]; VD(9-12h) 
= volume of distribution of the approximated steady-state-interval investigated [l]; Cl(9-12h) 
= clearance under the approximated steady-state-conditions [l/h]). 
 
Results 
Validity of the detection of taurultame and taurinamide by HPLC-MS 
The HPLC-MS/MS method (figures 1 and 2) was found to yield precise and reproducible 
results. For a within-study validation two replicates of human plasma samples spiked with 
taurolidine at two different concentrations (approx 2.5 and 20.0 µg/mL) in each run were 
analyzed. In all experiments, the concentration of taurolidine was back-calculated based on 
the measured concentration of taurultame and taurinamide. The calibration curves for 
taurultame and taurinamide could be described with linear functions with high precision 
(figure 2).  
The mean between-batch accuracy was found to be 112 % at 2.52 µg/mL nominal 
concentration (n=6) and 107 % at 18.1 µg/mL nominal concentration (n=6) for the ex vivo 
samples. For the in vitro experiments, the mean between-batch accuracy was found to be 
107 % at 2.66 µg/mL nominal concentration (n=6) and 115 % at 19.1 µg/mL nominal 
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concentration (n=6). The between batch variation coefficient was calculated as 8.7 ± 0.3 % 
for the ex vivo and 5.7 ± 0.6 % for the in vitro samples (Tables 1 and 2). 
 
Stability of taurolidine, taurultame and taurinamide in plasma 
In plasma, the concentrations of taurultame, taurinamide and taurolidine (back-calculated 
from the taurultame and taurinamide values) remained constant over a 6 hour period at 
37 °C (repeated measures-ANOVA, n.s.; figure 3). The taurultame-taurinamide-ratio 
(TTR) did not change in a statistically significant way over the 6 hour period (2.25 vs. 
2.85; repeated measures-ANOVA; n.s.). 
 
Table 2. Within-study validation of the total taurolidine concentration 
nominal concentration of 
taurolidine (µg/mL) 
Between-batch CV (%) 
[n = 6] 
Between-batch ACC (%) 
[n = 6] 
Ex vivo   
2.52 8.9 112 
18.1 8.5 107 
In vitro   
2.66 5.2 107 
19.1 6.1 115 
ACC = accuracy of the nominal concentration; CV = coefficient of variation 
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Figure 3. Concentration of taurultame, taurinamide and taurolidine (calculated from the taurultame 
and taurinamide values) in human plasma at 37 °C in vitro over 6 hours at an initial concentration 
of 100 µg/mL. There are no statistically significant changes of the concentrations. For details see 
methods. 
 
 
Stability of taurolidine, taurultame and taurinamide in whole blood 
In whole blood there was a time and concentration dependent conversion of taurolidine. 
During incubation at 37°C the concentration of taurultame decreased logarithmically at a 
rate which corresponded to the increase of the taurinamide concentration (figures 4 and 5).  
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Immediately following incubation the TTR was 0.95 at an initial taurolidine concentration 
of 50 µg/mL, and 1.69 at 100 µg/mL (t-test; p<0.05; figure 6). After 6h incubation, the 
TTR reached the value of 0.02, independent of the initial taurolidine concentrations (t-test, 
n.s.). The taurolidine concentration (back-calculated from the taurultame and taurinamide 
values) remained largely constant over the time period tested (figures 4 and 5). 
 
Figure 4. Concentration of taurultame, taurinamide and taurolidine (calculated from the 
taurultame and taurinamide values) in human whole blood in vitro at 37 °C over 6 hours (3 
experiments) at an initial taurolidine concentration of 50 µg/mL. Mean values ± SEM are given. 
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Figure 5. Concentration of taurultame, taurinamide and taurolidine (calculated from the 
taurultame and taurinamide values) in human whole blood in vitro at 37 °C over 6 hours at an 
initial taurolidine concentration of 100 µg/mL. Mean values ± SEM are given. 
 
Concentration of taurolidine in plasma following repeated infusion  
The calculated plasma concentration of taurolidine showed a strong increase after the start 
of each infusion and increased until the end of infusion, followed by a rapid decline 
(figure 7). The TTR was found to fluctuate between 0.1 and 0.3 depending on the relation 
to the previous or next infusion period (figure 6). Taurolidine and taurinamide showed a 
moderate accumulation over the 13 hour treatment period, whereas taurultame did not 
(figure 7).   
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Figure 6. Time course of the taurultame-taurinamide-ratio (TTR) in whole blood over 6 hours (3 
experiments) in vitro at 2 different initial taurolidine concentrations (filled circles and open 
triangles). Time course of the TTR in vivo over 13 hours during 4 repetitive taurolidine infusions in 
7 patients (filled squares). The calculated mean plasma concentration of taurolidine in these 
patients was 83.0 µg/mL (for details see Methods, Results and table 3). Mean values ± SEM are 
given. 
 
Pharmacokinetic parameters 
The average patient plasma concentration (back-calculated from the taurultame and 
taurinamide values) of taurolidine was found to be 83.0 µg/mL (figure 7, table 3). Thus, 
the taurolidine concentration was within the anti-neoplastic effective concentration range 
determined in vitro (Calabresi et al. 2001; Stendel et al. 2002; Stendel et al. 2003; Rodak et 
al. 2005).  
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Figure 7. Plasma concentrations of taurultame, taurinamide and taurolidine (calculated from the 
taurultame and taurinamide values) during 4 repetitive taurolidine infusions (mean values and SEM 
of 7 patients; infusion over 2 hours with an interval of 1 hour between infusions). The calculated 
mean plasma concentration of taurolidine (83.0 µg/mL) is within the anti-neoplastic effective 
concentration range determined in vitro. 
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Table 3. Pharmacokinetic data of seven patients during repetitive intravenous administration of 
taurolidine comprising four 5g infusions every 24 hoursa.  
 
Parameter Taurolidine  Taurultame Taurinamide 
Cmax (9-12) (µg/mL) 95.8 ± 21.8 17.0 ± 8.1 69.1 ± 19.1 
Cav (9-12) (µg/mL) 83.0 ± 18.1 13.6 ± 5.6 58.5 ± 15.6 
Cmin (9-12) (µg/mL) 61.3 ± 20.4 7.9 ± 4.6 46.9 ± 14.7 
t1/2 (9-12) (h) 1.7 ± 0.1 1.5 ± 0.2 1.7 ± 0.2 
AUC (9-12) (µg h/mL) 249.2 ± 58.4 40.7 ± 16.7 175.5 ± 46.5 
PTF (9-12) (%) 47.9 ± 18.8 80.1 ± 36.4 41.5 ± 15.4 
Vd (9-12) (L) 210.5 ± 45.8 289.6 ± 176.1 236.0 ± 67.4 
Cl (9-12) (L/h) 84.8 ± 20.7 138.4 ± 10.3 95.6 ± 26.9 
a) Values are expressed as mean ± SD 
AUC(9–12) = area under the plasma concentration-time curve from hours 9 through 12 following the 
start of the infusion; Cav(9–12) = average plasma concentration from hours 9 through 12 following 
the start of the infusion; Cmax(9–12) = maximum plasma concentration from hours 9 through 12 
following the start of the infusion; Cmin(9–12) = minimum plasma concentration from hours 9 
through 12 following the start of the infusion; CL(9–12) = apparent clearance from hours 9 through 
12 following the start of the infusion; PTF(9–12) = peak trough flow fluctuation from hours 9 
through 12 following the start of the infusion; t1/2(9–12) = elimination half-life from hours 9 through 
12 following the start of the infusion; V = volume of distribution from hours 9 through 12 
following the start of the infusion. 
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Discussion 
Using 1H- and 13C-NMR-spectroscopy (Erb et al. 1983; Hood et al. 1994), NMR 
spectroscopy and gas-chromatography (Knight et al. 1983) early studies have shown, that 
in aqueous solution taurolidine is present in an equilibrium of hydrolysis/hydration with 
taurultame and N-hydroxymethyl-taurultame.  
Following incubation of taurolidine in human plasma or protein-free serum in vitro, 
taurultame and taurinamide, but not taurolidine, have been identified (Jones et al. 1990). 
Furthermore, following intraperitoneal (Knight et al. 1981; Vankemmel et al. 1982; Erb et 
al. 1983) and intravenous (Vankemmel et al. 1982; Erb et al. 1983) taurolidine application 
in vivo taurultame and taurinamide could be detected in human blood serum samples, so 
that taurultame and taurinamide are regarded as main derivatives of taurolidine (Skellern 
1985; Waser et al. 1985). Similarly, using pre-column derivatization and HPLC with 
fluorescence detection (Woolfson et al. 1989), a conversion of taurolidine with subsequent 
formation of taurinamide has been observed in plasma (Jones et al. 1990). In the present 
study, taurolidine displayed a stable pattern of derivatives in plasma in vitro as nearly 
unchanged values of taurultame and taurinamide were found over 6 hours of incubation 
(figure 3). Taurolidine itself was below the limit of detection but was back calculated from 
the taurultame and taurinamide values. Since the ratio of metabolites was already stable at 
the first points of measurements (figure 3), the time period of plasma sample preparation (5 
min.) before freezing appears to be sufficient for the conversion of taurolidine to 
taurultame and taurinamide.  
In whole blood in vitro, a conversion of taurolidine was apparent in a time- and 
concentration-dependent manner (figures 4 and 5), with the TTR decreasing significantly 
(figure 6) as measured over a 6 hour period of incubation. These results point to two 
phases of taurolidine conversion in whole blood. During the first phase, the formation of 
taurultame and taurinamide occurs at a slower rate as compared to the nearly immediate 
formation of these two derivatives in plasma. The rate of conversion during the initial 
phase mainly depended on the initial concentration of taurolidine (figures 4 and 5) being 
significantly slower at the 50 µg/mL concentration than at 100 µg/mL. The second phase is 
characterized by a fairly linear kinetic profile and is markedly slower than the first one. 
Competitive binding of taurolidine to plasma proteins is unlikely, as indicated by the 
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results of experiments performed with radioactively labeled taurolidine dialyzed against 
human plasma (Steinbach-Lebbin et al. 1982). In whole blood in vitro binding of 
taurolidine to erythrocytes is postulated to explain the time course of the formation of its 
derivatives in whole blood in vitro.  
A commercial preparation of taurolidine for intravenous infusion is available as a 2% 
solution (Taurolin®). Taurolidine treatment of human glioblastomas is performed by 
repetitive intravenous infusions comprising four daily infusions of 2% taurolidine solution, 
each administered over 2 hours with a 1-hour interval between infusions using a total daily 
dose of 20 g (Stendel et al. 2002; Stendel et al. 2004). In the present study, this infusion 
regimen was reflected by the intermittent rising and falling of the plasma concentrations of 
taurolidine, taurultame and taurinamide (figure 7). Correspondingly, the ratio of taurultame 
to taurinamide (TTR) did not vary significantly over the treatment period of 13 hours 
(figure 6). The average plasma concentration of taurolidine (83.0 µg/mL) as calculated 
from the taurultame and taurinamide values was within the anti-neoplastic effective 
concentration range (Calabresi et al. 2001; Stendel et al. 2002; Stendel et al. 2003; Rodak 
et al. 2005). Thus, the infusion protocol chosen for the treatment of glioblastoma provides 
an adequate anti-neoplastic concentration of taurolidine.  
The previous knowledge on the pharmacokinetic behavior of taurolidine following 
repetitive intravenous administration in humans was very limited. Peak taurultame 
concentrations have been reported to be app. 4 µg/mL after continuous intravenous 
infusion of 15 g taurolidine (Vankemmel et al. 1982), and app. 5 µg/mL (Erb et al. 1983) - 
8.1 µg/mL (Vankemmel et al. 1982) after the second of three repetitive intravenous 
infusions of each 5 g taurolidine. It is difficult to interpret in the cited studies (Vankemmel 
et al. 1982; Erb et al. 1983) that the peak taurultame concentration during the third infusion 
was markedly below that during the second infusion. In addition, these values are at least 
two-fold lower as measured in the present study using the same taurolidine dose per 
infusion (table 3). The overall lower serum concentrations of taurultame in the cited 
studies (Vankemmel et al. 1982; Erb et al. 1983) as compared to the results of the present 
study may possibly be attributable to the different way of sample processing after blood 
collection. In the present study the plasma concentrations of taurolidine and taurinamide 
showed a moderate accumulation with the increasing number of infusions, whereas the 
concentration of taurultame did not (figure 7). This is probably due to the higher volume of 
distribution indicating a much higher concentration in tissue. In addition, the 
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pharmacokinetic parameters must be interpreted with caution because only 3 blood 
samples were collected for each administration interval. Furthermore, the basis for the 
calculation of the pharmacokinetic parameters was only an approximation of a steady-
state-condition.  
 
Conclusions 
A new method for quantitative determination of taurultame and taurinamide in human 
plasma has been developed. Taurultame and taurinamide concentrations were determined 
with high accuracies using HPLC and tandem mass spectrometry permitting a 
quantification of taurolidine concentrations. 
Taurolidine displayed a stable pattern of derivatives in human plasma in vitro. In whole 
blood taurolidine is converted to taurultame and taurinamide in a time- and concentration-
dependent manner. 
The average taurolidine plasma concentration achieved with the repetitive infusion 
regimen in glioblastoma patients is within the anti-neoplastic effective concentration range. 
The volume of distribution is higher than plasma volume, suggesting that tissue 
concentrations of taurolidine, taurultame and taurinamide are markedly higher than plasma 
concentrations. Repetitive infusion of taurolidine is the therapeutically adequate mode of 
administration for the indication of glioblastoma. 
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5.4. The Modified Flavonol Glycosylation Profile in the 
Arabidopsis rol1 Mutants Results in Alterations in 
Plant Growth and Cell Shape Formation 
 
Abstract 
Flavonoids are secondary metabolites known to modulate plant growth and development. 
A primary function of flavonols, a subgroup of flavonoids, is thought to be the 
modification of auxin fluxes in the plant. Flavonols in the cell are glycosylated and the 
rol1 mutants of Arabidopsis thaliana, affected in rhamnose biosynthesis, have a modified 
flavonol glycosylation profile. A detailed analysis of the rol1-2 allele revealed hyponastic 
growth, aberrant pavement cell and stomatal morphology in cotyledons, and defective 
trichome formation. Blocking flavonoid biosynthesis suppresses the rol1-2 shoot 
phenotype, suggesting that it is induced by the modified flavonol profile. The hyponastic 
cotyledons of rol1-2 are likely to be the result of a flavonol-induced increase in auxin 
concentration. In contrast, the pavement cell, stomata, and trichome formation phenotypes 
appear not to be induced by the modified auxin distribution. Together, these results suggest 
that changes in the composition of flavonols can have a tremendous impact on plant 
development through both auxin-induced and auxin-independent processes. 
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Introduction 
Flavonoids represent a highly diverse class of low molecular weight secondary 
metabolites, of which >6000 different compounds have been described. They are important 
for pigmentation and UV-protection. They serve as signals for pollinators and other 
beneficial organisms, participate in hormone signaling and function as phytoalexins. A 
number of biological processes such as transcriptional regulation, signal transduction, and 
cell-to-cell communication are influenced by flavonoids. Due to their antioxidant activity, 
flavonoids appear to play an important role in the control of reactive oxygen species (ROS) 
in plant cells (Lepiniec et al., 2006; Peer and Murphy, 2006). In Arabidopsis thaliana, 24 
mutants have been identified on the basis of aberrant flavonoid accumulation (Routaboul et 
al., 2006). Frequently, mutants are defective in the biosynthesis of proanthocyanidins 
(Figure 1), the subgroup of flavonoids responsible for seed coloring (Korneef, 1990; 
Debeaujon et al., 2003; Lepiniec et al., 2006), and thus deviate from the typical brown seed 
color. The flavonols, kaempferol, quercetin, and isorhamnetin, constitute a subgroup of 
flavonoids that appears to be present in all tissues of Arabidopsis. They are O-
glycosylated, mainly by glucose and rhamnose units at the C3 and C7 positions, resulting 
in a large number of different molecules (Veit and Pauli, 1999; Lepiniec et al., 2006). 
Biochemical experiments and analyses of auxin fluxes in flavonoid-deficient mutants 
suggest that flavonols negatively regulate auxin transport (Jacobs and Rubery, 1988; 
Brown et al., 2001; Buer and Muday, 2004; Peer et al., 2004). There is also evidence that 
flavonols directly influence cell growth. In petunia and maize, chalcone synthase mutants 
are blocked in the first step of flavonoid-biosynthesis (Figure 1) and are defective in pollen 
tube growth. Kaempferol was identified as the pollen germination-inducing constituent 
when applied to mutant stigma (Mo et al., 1992). In addition, the petunia mutant is 
defective in root-hair development (Taylor and Grotewold, 2005). 
Cell growth is largely determined by the extension rate of the cell wall, which is a complex 
structure composed of the polysaccharides cellulose, hemicellulose, and pectin, in addition 
to a number of structural proteins (Carpita and Gibeau, 1993; Cassab, 1998). Epidermal 
leaf pavement cells provide a model system in which to study the process of cell growth 
and determination of cell shape (Mathur, 2004). In Arabidopsis, pavement cells have a 
jigsaw puzzle-like shape where lobes extend into neighboring cells. This pattern is based 
on coordinated outgrowth at a given point in one cell, with inhibition of outgrowth in the 
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Previously, we identified two allelic rol1 (repressor of lrx1) mutants, which suppress the 
Arabidopsis root-hair mutant lrx1 (Diet et al., 2006). LRX1 encodes an extracellular LRR-
extensin protein, specifically expressed in root hairs (Baumberger et al., 2001; Ringli, 
2005). While lrx1 mutants develop defective root hairs, lrx1 rol1 double mutants show a 
suppressed lrx1 phenotype and form wild-type-like root hairs. The ROL1 locus encodes 
RHM1, one of three rhamnose synthase proteins that convert UDP-D-Glucose to UDP-L-
Rhamnose in Arabidopsis (Diet et al., 2006; Oka et al., 2007). The RHM1 protein encoded 
by the rol1 mutants is unable to catalyze this conversion (Diet et al., 2006). Rhamnose is 
an important component of pectin (Ridley et al., 2001) and the rol1 mutants exhibit 
modifications in pectin structure (Diet et al., 2006), which may provide the molecular basis 
of the observed suppression of the lrx1 root-hair phenotype. Seedlings of both rol1 alleles 
also develop cotyledons with an uneven surface and the peripheral zone that is bent 
upwards. This is referred to as hyponastic growth and is the result of asymmetric growth of 
the adaxial and abaxial (upper and lower, respectively) surfaces of the cotyledon (Kang, 
1979). In addition, the stronger rol1-2 allele develops slightly shorter roots and shorter root 
hairs than wild-type seedlings (Diet et al., 2006). 
In this work, we show that the rol1 mutants contain a modified flavonol glycosylation 
profile. A detailed analysis of the rol1-2 allele revealed aberrantions in cell shape, which 
result in over-sized cotyledon pavement cells that lack typical lobes and have defective 
trichomes. Genetic experiments suggest that it is a change in the flavonol profile that 
induces the observed cotyledon and trichome phenotypes. Our results suggest that the shift 
in flavonol abundance results in a change of auxin concentration, inducing hyponastic 
growth in cotyledons. In addition, the modified flavonol profile appears to have a direct 
effect on cell formation that is independent of its effect on the auxin concentration. This 
suggests that flavonols can directly interfere with cell growth processes. 
 
Results 
Flavonol accumulation is modified in rol1 mutants 
For the analysis of flavonol accumulation, wild-type, rol1-1, and rol1-2 seedlings were 
grown for six days on MS-Agar plates in a vertical orientation. At this stage of seedling 
development, cotyledons are fully expanded and the first true leaves are about to form. 
Seedlings were cut in the hypocotyl, and shoot- and root tissues were separately pooled 
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adjacent cell. The underlying signaling network that controls this process involves a 
complex activation / inactivation interaction between ROP2 and RIC1 / RIC4 (Fu et al., 
2005). ROP (Rho-related GTPase of plants) proteins regulate the organization of cortical 
microtubules and actin microfilaments (Smith, 2003; Fu et al., 2005). Indeed, interfering 
with actin filament nucleation changes pavement cell shape (Frank et al., 2003; Mathur et 
al., 2003; Djakovic et al., 2006). Recently, the TREHALOSE-6-PHOSPHATE 
SYNTHASE mutant, csp1, was shown to cause a pavement cell phenotype, though the 
function of trehalose-6-phosphate in this process remains unclear (Chary et al., 2007). The 
importance of the cell wall in cell-shape determination is well know and is reflected by the 
fact that the cellulose synthase mutant rsw1 lacks lobe formation in pavement cells, 
resulting in straight cell boundaries (Williamson et al., 2001). 
 
Figure 1. Biosynthesis of flavonoids in Arabidopsis.  
Flavonoids are made of three molecules of Malonyl CoA and one molecule of p-Coumaroyl CoA. 
Flavonols are a subgroup of flavonoids and commonly consist of glycosylated kaempferol, 
quercetin, and isorhamnetin derivatives. transparent testa (tt) mutants of Arabidopsis are flavonoid 
biosynthesis mutants characterized by a change in seed color due to the absence of 
proanthocyanidins. The tt4 mutant is deficient in chalcone synthase, resulting in the absence of 
flavonoids. 
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and analyzed. The targeted metabolite analysis was performed by HPLC-MS, as described 
in the METHODS section. Most flavonol glycosides were identified by their UV-
absorption spectra, MS/MS analysis, and by comparison with reference compounds of 
known structure. Recently published data was also used to interpret results (Kerhoas et al., 
2006; Le Gall et al., 2006; Stobiecki et al., 2006; Veit et al., 1999). Flavonol levels were 
obtained by calculating the area below each HPLC-peak per milligram dry weight of plant 
material.  
Figure 2A shows the elution profile of shoot extracts. Several changes were observed 
between wild type and the rol1 mutants. Some flavonols were less abundant than in wild-
type tissues, while others were elevated in the rol1 mutants. Flavonol aglycones were not 
detected in any of the plant lines analyzed. 
 
 
wild-type 
rol1-1 
rol1-2 
Fig. 2(A) 
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Com-
pound MW X Y Z Trivial Name 
accumulation 
in rol1-1 
seedlings 
accumulation 
in rol1-2 
seedlings 
tissue of 
detection in 
wild-type 
1 740 α-rha α-rha(12)β-glc H K-R-G-3-R-7 0.5 0.4 shoot and root 
2 756 α-rha α-rha(12)β-glc OH Q-R-G-3-R-7 0.6 0.6 shoot and root 
3 756 ? ? OH Q-G-R-R * 0.1 0.1 mainly root 
4 772 α-rha β-glc(16)β-glc OH Q-G-G-3-R-7 1.1 0.4 mainly root 
5 578 α-rha α-rha H K-R-3-R-7 0.2 0.1 mainly shoot 
6 594 β-glc α-rha H K-R-3-G-7 2.6 2.1 mainly shoot 
7 594 α-rha β-glc H K-G-3-R-7 ** **  
8 610 β-glc β-glc H K-G-3-G-7 4.7 4.3 shoot and root 
9 594 α-rha α-rha OH Q-R-3-R-7 ** **  
10 610 α-rha β-glc OH Q-G-3-R-7 0.9 0.6 shoot and root 
11 610 OH α-rha(12)β-glc OH Q-R-G-3 2.7 0.8 root 
12 624 α-rha β-glc OCH3 I-G-3-R-7 1.6 1.2 shoot and root 
13 432 OH α-rha H K-R-3 10 4 shoot 
14 448 OH β-glc H K-G-3 40 40 shoot and root 
15 464 OH β-glc OH Q-G-3 40 50 shoot and root 
16 478 OH β-glc OCH3 I-G-3 34 58 mainly root 
Figure 2. Flavonol accumulation is modified in rol1 mutants.  
Flavonols were extracted from Arabidopsis seedlings grown for six days in a vertical orientation.  
(A) Flavonol elution profiles obtained from HPLC-(–)-ESI-MS analyses. In order to improve the 
selectivity, the sums of the extracted ion chromatograms corresponding to flavonoid derivatives 1 
to 16 are displayed (EIC of m/z 431, 447, 463, 477, 577, 593, 609, 623, 739, 755, 771). 
Glucobrassicin derivatives [peaks Nr. 17 (m/z 447), 18, and 19 (both m/z 477)] are non-flavonoid 
compounds that are listed because they show the same mass spectra as some flavonoid derivatives. 
(B) The flavonol structure is given. The groups at the C7, C3, and C3’ positions are listed in the 
table (X, Y, Z, respectively). The flavonoid accumulation of the single components is represented 
by the factor of induction / repression in rol1 mutants compared to wild type that was determined 
on whole-seedling extracts. The substances are numbered according to the chromatograms in (A). 
To determine tissue-specificity of flavonol accumulation, seedlings were cut in the hypocotyl and 
upper (shoot) and lower (root) tissue was collected and extracted separately. Detection in mainly 
one tissue was defined as a ≥5 fold overaccumulation of the compound in one tissue compared to 
the other. Only two compounds accumulated exclusively in one tissue (11 and 13). K= kaempferol, 
Q=quercetin, I=isorhamnetin, G=Glucose, R=Rhamnose. * The exact structure of this compound 
could not be identified. ** The factor of induction / repression could not be determined because 
peak Nr. 7 and 9 are coeluting and have identical molecular weights. 
 
O
O
X
OH
Y
7
3
OH
Z
3'
Fig. 2(B) 
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Figure 2B shows the exact structure of each of the identified flavonol species and the 
induction/repression factor in the rol1 mutants compared to the wild type. The two rol1 
alleles revealed a comparable profile. A reduction of up to tenfold was found in rol1 
mutants for flavonols glycosylated with several rhamnose units. Some flavonols containing 
single rhamnose units, such as kaempferol-3-O-rhamnose (K-R-3; Figure 2, peak #1), 
however, are increased several-fold. The clearest alteration in rol1 mutants was found for 
the 3-O-glucosides of kaempferol (kaempferol-3-O-glucose; K-G-3), quercetin (quercetin-
3-O-glucose; Q-G-3), and isorhamnetin (isorhamnetin-3-O-glucose; I-G-3) (Figure 2, 
peaks #3, 4, 5, respectively). While the first two are strongly induced, particularly in the 
shoot (factor of 57 to 92), I-G-3 newly accumulates in shoots and overaccumulates in roots 
of rol1 mutants. One flavonol (MW 490; Figure 2, peak #6) has yet to be identified in 
Arabidopsis. Based on MS/MS analysis and the analysis of the rol1-2 tt7 double mutant 
(see below), this flavonol is a kaempferol and therefore referred to as K-uk (unknown 
kaempferol). According to the literature, it may be a kaempferol-3-O-(6’’-acetyl-
glucoside), which has been found in needles of Pinaceae species (Slimestad, 2003). 
The relative abundance of each flavonol compound in the different lines is shown in 
Supplemental Figure 1A. Calculating the total amounts of shoot and root flavonols 
revealed a decrease by 25% in the shoot of the rol1 mutants and an increase by 30% (rol1-
1) and 10% (rol1-2) in roots (Supplemental Figure 1B) compared to wild type. Since the 
two rol1 alleles showed comparable changes in the flavonol profile, we decided to limit 
further analyses to the rol1-2 allele, which shows a stronger phenotype (Diet et al., 2006). 
Flavonoids were visualized in vivo with diphenylboric acid-2-aminoethyl ester (DPBA), a 
flavonoid-specific stain, which binds flavonols (Buer et al., 2007). In agreement with 
previous reports (Peer et al., 2001), fluorescence was found in the cotyledonary node, the 
root/shoot transition zone, the root elongation zone, and very faintly in trichomes of wild-
type plants. In rol1-2 mutants, increased fluorescence was detected in the root-elongation 
zone and in trichomes (Supplemental Figure 2). No increase in DPBA-staining was 
observed in the cotyledonary node. To confirm that the observed fluorescence was due to 
the presence of flavonoids, a rol1-2 tt4 double mutant was generated and analyzed. tt4 
plants carry a mutation in the CHALCONE SYNTHASE gene and are thus blocked in the 
first step of flavonoid biosynthesis (Shirley et al., 1995; Figure 1). As shown in Figure 2A, 
the flavonol-peaks are indeed absent in rol1-2 tt4 extracts. These plants also fail to produce 
fluorescence, other than a faint background staining in root tissue (Supplemental Figure 2). 
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Fig. S1 (A) 
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Supplemental Figure 1. Graphical representation of flavonol abundance in wild type 
and rol1 mutant seedlings.  
(A) The distribution of the flavonol species in shoots and roots in the different lines is shown for 
each identified flavonol. The amount of flavonol was defined as the area under the corresponding 
HPLC-peak and calculated per milligram dry weight. Note the difference in the scale, i.e. the 
abundance of the different flavonols. Red bar: Two obvious candidates for a function in rol1-2. 
They accumulate to higher levels in rol1 mutants compared to the wild type and are present in all 
lines showing the rol1-2 phenotype. (B) Total amounts of flavonols in the different lines. Means ± 
SE of 3 samples are shown.  
Fig. S1 (B) 
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Supplemental Figure 2. Flavonoid staining by DPBA in Arabidopsis seedlings. 
Seedling shoots [(A)-(D)] of wild type, rol1-2, tt4, and rol1-2 tt4 mutants were stained with DPBA 
and analyzed by fluorescence microscopy. DPBA fluorescence is shown in green while the red 
color represents chlorophyll autofluorescence. Flavonoids are more abundant in trichomes of rol1-
2 mutants, and absent in tt4 or rol1-2 tt4 mutants. The insets show better visualization of trichome 
flavonol fluorescence. Wild type roots (E) show weaker fluorescence than do rol1-2 roots (F) 
while rol1-2 tt4 double mutant roots (G) reveal only background staining of the dye. The root tips 
are indicated by arrows. All photographs were taken at identical settings to allow comparisons in 
the fluorescence intensities. Bar [(A)-(D)] = 0.5 mm, Bar [(E)-(G)] = 0.5 mm To investigate the 
distribution of flavonoids in vivo, wild-type and rol1-2 seedlings were stained with diphenylboric 
acid-2-aminoethyl ester (DPBA), which forms fluorescent complexes with flavonoids. In 
agreement with previous reports (Peer et al., 2001), fluorescence in wild-type plants was found in 
the cotyledonary node, the root/shoot transition zone, and the root elongation zone. In rol1-2 
mutants, fluorescence was strongly increased in the root and observed in trichomes, which in wild-
type plants are void of DPBA-detectable flavonoids (Figure S1). No increase in DPBA-staining 
could be observed in the cotyledonary node.  
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The rol1-2 mutant develops several shoot phenotypes  
rol1-2 mutants show aberrant cotyledon development, with an uneven cotyledon surface 
and hyponastic growth. In addition, trichomes of the first rosette leaves are strongly 
deformed in rol1-2 (Diet et al., 2006; Figure 3A and 3B). The cotyledon growth phenotype 
was investigated in more detail by scanning electron microscopy (SEM). Compared to the 
wild type, the size of adaxial pavement cells is frequently increased (Figure 4A and 4B) 
and the typical jigsaw puzzle-like cell shape of pavement cells is absent in rol1-2 mutants 
(cell borders are straight and the characteristic lobes are absent, see Figure 4C and 4D). 
This phenotype is restricted to the abaxial site of the cotyledon. In the SEM analysis, 
stomatal distribution appeared to be affected in rol1-2 cotyledons. Stomata were therefore 
visualized by confocal microscopy using FM4-64. rol1-2 plants have fewer stomata than 
wild-type plants (34 ± 8 per mm2 versus 163 ± 26 ) and the stomata are frequently larger 
than those of wild type (Figure 4I and 4J). 
 
 
Figure 3. Aberrant cotyledon and 
trichome formation in rol1-2 mutants.  
(A) to (E) Cotyledons and leaves of 5- and 8-d-
old Arabidopsis plants. 
(A) Wild type. 
(B) rol1-2. The periphery of cotyledons is bent 
upward, referred to as hyponastic growth. 
Also, the surface of rol1-2 mutant cotyledons 
is rough and contains bulging epidermal cells 
(arrow). Trichomes are frequently deformed. 
(C) The features of the rol1-2 phenotype are 
suppressed by the tt4 mutation in rol1-2 tt4 
double mutants. 
(D) and (E) No suppression of the rol1-2 
phenotype is observed in rol1-2 tt7 (D) or rol1-
2 ugt78d1 (E) double mutants. 
(F) and (G) The anthocyanin-less rol1-2 tt4 
mutant (F) is chemically complemented by 
naringenin (G). The arrow in (G) indicates the 
area shown in the inset. Colocalization of 
anthocyanin and epidermal bulging is indicated 
by arrowheads in the inset. 
Bars = 1 mm. 
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Figure 4. Pavement cell and 
stomata phenotypes in rol1-2 
mutants. 
Scanning electron micrographs from  
5-d-old cotyledons. Wild-type plants 
develop jigsaw puzzle–like pavement 
cells ([A] and [C]), whereas lobe 
formation is suppressed in rol1-2 
mutants ([B] and [D]), resulting in 
brick-like cells. Also, cells are 
frequently oversized compared with 
those in the wild type. The pavement 
cell phenotype induced by the rol1-2 
mutation is suppressed by the tt4 
mutation (E). tt4 single mutants develop 
pavement cells that are 
indistinguishable from those in the wild 
type (F). tt7 and ugt78d1 do not 
suppress the rol1-2 phenotype in the 
corresponding double mutants ([G] and 
[H]). Compared with the wild type (I), 
stomata of cotyledons are larger in rol1-
2 (J), an effect that is suppressed in the 
rol1-2 tt4 double mutant (K). Treatment 
of the wild type with NPA does not 
change the size of stomata (L). 
Bars = 250 µm in (A) and (B), 100 µm 
in (C) to (H), and 20 µm in (I) to (L). 
 
The rol1-2 shoot phenotypes are flavonoid-dependent 
To investigate the role of modified flavonoid accumulation in the development of the rol1-
2 phenotype, the flavonoid-less rol1-2 tt4 double mutant was characterized. In the double 
mutant, the hyponastic growth and trichome formation phenotypes observed in the rol1-2 
single mutants were fully suppressed (Figure 3C). This indicates that the rol1-2 mutant 
shoot phenotypes are related to the change in flavonol accumulation, a finding that was 
confirmed by SEM analysis. In rol1-2 tt4 double mutants, pavement-cell shape is reverted 
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to wild type (Figure 4E). tt4 single mutant plants also develop wild type-like pavement 
cells (Figure 4C and 4F). Furthermore, the size (Figure 4K) and density (142 ± 13 per 
mm2) of stomata in rol1-2 tt4 cotyledons is again comparable to wild type. 
To confirm co-segregation of the tt4 mutation with suppression of the rol1-2 mutant 
phenotypes, seedlings homozygous for rol1-2 but segregating for tt4 were grown. Of 460 
seedlings analyzed, 126 showed a lack of anthocyanin accumulation, typical of 
homozygous tt4 mutants (Shirley et al., 1995), and suppression of the rol1-2 shoot 
phenotypes. This corresponds to the expected 3:1 wild-type:mutant segregation of the 
recessive tt4 mutation (χ2-test, P=0.05) and indicates a close linkage between the tt4 
mutation and the locus that suppresses the rol1-2 mutant shoot phenotypes. 
In a second approach, we tested the chemical complementation of the tt4 mutation in the 
rol1-2 tt4 double mutant using naringenin, a flavonoid precursor positioned downstream of 
tt4 (Figure 1; Shirley et al., 1995). Growing rol1-2 tt4 double mutants in the presence of 
naringenin induced the accumulation of anthocyanin, confirming the uptake and metabolic 
processing of naringenin in the seedlings. At the same time, naringenin induced hyponastic 
growth and the irregular cell shapes characteristic of the rol1-2 mutation (Figure 3F and 
3G), indicating that the effect of the tt4 mutation is suppressed in the presence of 
naringenin. Together, our genetic and chemical complementation experiments suggest that 
the tt4 mutation suppresses the rol1-2 mutation and, hence, that flavonols are involved in 
the development of the rol1-2 shoot phenotype. 
 
The rol1-2 phenotype is modified by kaempferol derivatives 
In order to restrict flavonol accumulation more specifically, the rol1-2 mutation was 
crossed into the tt7 mutant background. The tt7 mutant is defective in flavanone-3’-
hydroxylase, which converts dihydrokaempferol to dihydroquercetin, and thus inhibits the 
accumulation of quercetin and isorhamnetin, while kaempferol accumulates to higher 
levels (Figure 1; Peer et al., 2001). The effect of tt7 on flavonol accumulation was 
confirmed in rol1-2 tt7 double mutants (Supplemental Figure 1A), which show almost no 
accumulation of quercetin or isorhamnetin. The increase in kaempferol accumulation is 
more pronounced in roots than in shoots, indicating that the tt7 mutation might have 
distinct effects on the activity of the flavonoid biosynthesis pathway in these tissues. rol1-2 
tt7 seedlings develop a rol1-2 phenotype (Figure 3D and 4G), suggesting that the rol1-2 
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phenotype-inducing flavonols are kaempferols. The tt7 single mutant and the 
corresponding wild type Landsberg erecta do not develop a rol1-2 phenotype 
(Supplemental Figure 3), thus demonstrating that the increased accumulation of 
kaempferols, per se, does not cause the rol1-2 phenotype. 
 
Supplemental Figure 3. The tt7 mutation does not develop rol1-2 like phenotypes. 
Wild type Landsberg erecta (Ler) (A) and tt7 (B) seedlings develop epinastic cotyledons and 
normal trichomes. Gel prints of pavement cells (C) reveal no difference between wild type and the 
tt7 mutant. For comparison, a gel print of a rol1-2 tt7 double mutant reveals the absence of the 
typical jigsaw puzzle-like cell shapes due to the rol1-2 mutation. 
Bars = 1 mm [(A) and (B)], 100 µm (C). 
 
rol1-2 was also combined with the UDP-rhamnose:flavonol-3-O-rhamnosyltransferase 
mutant ugt78d1 (Jones et al., 2003). This double mutant contains reduced amounts of 3-O-
rhamnosylated flavonols (Supplemental Figure 1A), but develops a rol1-2 like phenotype 
(Figure 3E and 4H). 
The flavonol(s) that cause the observed rol1-2 phenotype should be more abundant in the 
rol1 mutants than in wild-type plants and they should also be present in the rol1-2 tt7 and 
rol1-2 ugt78d1 double mutants. Based on these assumptions, K-G-3 and K-uk are the best 
candidates as causal agents for the rol1-2 phenotype. In Landsberg erecta and tt7, these 
flavonols are absent or present in very small amounts compared to rol1-2 (Figure 5). 
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Hence, the abundance of these two flavonol glucosides correlates with, and therefore may 
be responsible for the observed rol1-2 phenotype. 
 
Figure 5. The abundance of K-G-3 and K-uk correlates with the rol1-2 shoot 
phenotype. 
K-G-3 and K-uk [potentially kaempferol-3-O-(6’’-acetyl-glucoside)] fulfill the predicted 
requirements for the flavonol species that cause the rol1-2 shoot phenotypes. Both are found in 
small amounts (K-G-3) or are absent (K-uk) in the wild type (Columbia and Landsberg erecta) and 
tt7 but are present in rol1, rol1-2 tt7, and rol1-2 ugt78d1. Mean ± SE amounts of shoot flavonols 
are shown (n = 3). The area under the HPLC peak was used as the measurement for the amount of 
the flavonols. 
 
The modified flavonol profile of rol1-2 does not influence root-hair formation. 
Suppression of the lrx1 root-hair formation phenotype in the lrx1 rol1-2 double mutant was 
attributed to rol1-2 induced modifications in the cell wall (Diet et al., 2006). The drastic 
effect on cell growth caused by the modified flavonols prompted us to investigate their role 
in root-hair development and the suppression of lrx1. The lrx1 mutant root-hair phenotype 
(Figure 6A and 6B; Baumberger et al., 2001) is suppressed in the lrx1 rol1-2 double 
mutant, where root hairs form, though with reduced length compared to wild type (Figure 
6C; Diet et al., 2006). The absence of flavonoids in the lrx1 rol1-2 tt4 triple mutant does 
not influence suppression of lrx1 through rol1-2 (Figure 6D). 
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Figure 6. Flavonoid independence of root hair development. 
Seedlings were grown for 5 d in a vertical orientation. The lrx1 mutant root hair phenotype 
(compare [A] and [B]) is suppressed by the rol1-2 mutation (C). This suppression is not dependent 
on the flavonols in rol1-2, since the lrx1 phenotype is also suppressed in lrx1 rol1-2 tt4 triple 
mutants (D). The absence of flavonoids in the tt4 mutant does not have a significant effect on root 
hair formation (E) or on the rol1-2 mutant phenotype (compare [F] and [G]). Bar = 0.5 mm 
To investigate the effect of tt4 on root development, the visual root-hair phenotype, root 
length and root-hair length and density was determined in wild-type, rol1-2, tt4, and rol1-2 
tt4 seedlings. tt4 mutants show a wild-type-like root-hair phenotype and the tt4 mutation 
does not influence the rol1-2 root-hair phenotype (Figure 6E-G). Measuring root-hair 
length confirmed that neither the wild type nor rol1-2 mutant root-hair length is influenced 
by the tt4 mutation (Figure 7A). While root length is comparable between wild type and tt4 
mutants, the tt4 mutation partially (t-test, P=0.01) suppresses the short-root phenotype of 
the rol1-2 mutant (Figure 7B). The root-hair density is reflected by the length of root-hair-
forming trichoblasts. rol1-2 mutants develop shorter trichoblasts compared to wild type 
(Figure 7C; Diet et al., 2006), resulting in a higher root-hair density. While the length of 
trichoblasts of tt4 mutants and the wild type are comparable, the tt4 mutation partially (t-
test, P=0.01) suppresses this aspect of the rol1-2 mutant. The same result was found for 
atrichoblasts, which lack root hairs (Figure 7C).  
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Figure 7. Quantification of the root phenotypes in the different lines. 
Five-day-old seedlings were used for the quantification of root hair length (A), root length (B), and 
epidermal cell length (C). Trichoblasts are root hair–forming root epidermal cells, and atrichoblasts 
are root hair–less root epidermal cells. Means ± SE are shown (n = 25). Col, Columbia wild type. 
Hence, the increase in root length of rol1-2 tt4 double mutants compared to rol1-2 is 
paralleled by an increased length of the root epidermal cells. Together, these results 
indicate that the root phenotype of rol1-2, including the suppression of the lrx1 phenotype, 
is largely determined by the effect of the rol1-2 mutation on the cell-wall structure. The 
modified flavonol profile of rol1-2 seedlings has a small but significant influence on root 
development. 
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Auxin levels are increased in rol1-2 mutants 
Flavonols are known to be negative regulators of auxin transport (Buer and Muday, 2004; 
Peer et al., 2004). In order to establish whether the modified flavonol profile in rol1-2 
mutants influences auxin distribution, we measured free auxin concentrations in cotyledons 
and roots of six-day-old seedlings. As shown in Figure 8A, the amount of auxin was 
increased in cotyledons of rol1-2 mutants compared to that of wild type plants, and was 
restored to wild-type levels in rol1-2 tt4 double mutants. In the roots of the same plants, no 
significant changes in auxin levels were observed. 
These results indicate that the increased levels of auxin in rol1-2 shoots correlate with the 
observed mutant phenotypes. To investigate this further, we inhibited auxin transport using 
1-N-naphthylphthalamic acid (NPA) to determine whether this could phenocopy the rol1-2 
mutation. Wild type seedlings grown for six days in the presence of 5 µM NPA developed 
hyponastic cotyledons (Figure 8B), mimicking the effects of the rol1-2 mutation. Trichome 
and pavement cell shape were not affected by this treatment (Figure 8B and 8C), neither 
was the size of the stomata (Figure 4L). However, the density of stomata was reduced 
(i.e.119 ± 10 per mm2 for treated versus 163 ± 26 per mm2 for untreated seedlings), yet this 
reduction in density was not to the same degree as that observed in rol1-2 (34 ± 8 per 
mm2). These results suggest that the increase in auxin concentration affects stomatal 
density, while having no effect on the shape of pavement cells, trichomes, or the size of 
stomata. In a control experiment using Columbia wild type seedlings transformed with the 
auxin-sensitive DR5:GUS construct (Ulmasov et al., 1997), treatment with 5 µM NPA 
resulted in hyponastic cotyledons and strongly increased GUS activity when compared to 
un-treated sibling plants (Supplemental Figure 4). 
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Figure 8. Auxin levels are modified in the rol1-2 mutant. 
(A) Auxin concentration in the different plant lines was measured for shoots and roots of 6-d-old 
seedlings. Means ± SE are shown (n = 3). The rol1-2 mutation causes a significantly increased 
concentration of auxin in the shoot compared with the Columbia wild type. This effect is reversed 
by the presence of the tt4 mutation. DW, dry weight. 
(B) The hyponastic growth of rol1-2 cotyledons can be mimicked by growing wild-type or  
rol1-2 tt4 plants on 5 mM NPA (an auxin transportinhibitor). 
(C) NPA does not influence pavement cell shape in wild-type or rol1-2 tt4 plants. Gel prints taken 
from the adaxial side of cotyledons are shown. 
Bars = 100 µm 
 
C 
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To determine whether alterations in pavement cell shape and trichome formation, in rol1-2 
mutant plants, are caused by the combination of the effect of the rol1-2 mutation on the 
cell-wall structure (Diet et al., 2006) and auxin concentration, rol1-2 tt4 double mutants 
were grown in the presence of 5 µM NPA. The NPA treatment of these double mutants 
induced hyponastic cotyledons, but did not affect trichome development or pavement cell 
shape (Figure 8B and 8C). These data suggest that the hyponastic cotyledon phenotype of 
rol1-2 mutants results from increased auxin levels caused by the altered flavonol profile of 
these plants. These changes to the flavonol profile affect trichome and pavement cell 
shapes, through an unknown mechanism, independent of auxin. 
 
Figure S4. Effect of NPA on seedling development and DR5:GUS activity. 
Wild-type seedlings containing the auxin-sensitive DR5:GUS reporter construct were grown with 
(right) or without (left) 5 µM NPA in a vertical orientation and stained for GUS activity. In the 
presence of NPA, seedlings show hyponastic growth and strongly increased GUS activity.  
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Discussion 
The Arabidopsis UDP-L-RHAMNOSE SYNTHASE mutant alleles of rol1 are affected in the 
flavonol glycosylation profile. Compared to wild type, rol1 mutants contain strongly 
reduced amounts of flavonols glycosylated with multiple rhamnose units, while flavonols 
with single rhamnose units are, sometimes, even more abundant in rol1 mutants. The 
concomitant strong increase in mono-glucosylated flavonols in rol1 seedlings might be a 
compensatory effect of the limited rhamnose availability. The metabolite analysis suggests 
that flavonol glycosylation is altered with preferential conjugation at the C3-position and a 
redirection towards glucosylation. Compared to the wild type, there is a reduction in total 
amounts of flavonols in the shoots and an increase in the roots of the rol1 mutants. The 
increase of DPBA-induced fluorescence in rol1-2 trichomes seems to be at odds with the 
reduced amounts of flavonols in the shoot. This discrepancy can be explained by the small 
number of cells represented by trichomes compared to the total number of cells in the 
shoot The increased amounts may reflect a difference in the biosynthesis or turn-over rate 
of different flavonol species. Alternatively, flavonols may accumulate differentially in 
certain tissues by a directed transport mechanism (Buer et al., 2007). The possibility that 
the rol1-2 phenotype is induced by a non-flavonoid compound that is modified as a 
secondary indirect effect of rol1-2 can not be ruled out. However, the suppression of rol1-
2 by tt4 and chemical complementation by naringenin, makes this scenario less plausible. 
Our data suggest that changes in the flavonol conjugation pattern in rol1-2, i.e. an increase 
of one or several flavonol species, may interfere mainly with shoot development, while the 
complete removal of these conjugates may allow the plant to resume normal shoot 
development. Even though there is a measurable effect of the flavonols on rol1-2 root 
development, this process appears to be predominantly influenced by the modified cell-
wall composition of rol1-2 (Diet et al., 2006). Indeed, cell walls are known to be a key 
determinant of cell expansion (Martin et al., 2001). 
The changes in the pavement cell shape are only observed on the adaxial side of 
cotyledons, whereas the abaxial side appears to be unaffected. This may be due to 
overlapping expression patterns of the (assumed) functionally redundant genes RHM1 (i.e. 
ROL1) to RHM3 (Reiter and Vanzin, 2001). A very similar pavement cell phenotype is 
restricted spatially to the adaxial side of cotyledons, in the ROP-interacting protein mutant 
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icr1 (Lavy et al., 2007), suggesting a coordinated regulation of this process. It is an 
attractive hypothesis that under natural conditions, plants have the potential to modify the 
flavonol glycosylation profile as a mean to modulate growth and development. 
Interestingly, the absence of flavonoids appears to have no significant effect on cell growth 
or cell shape in Arabidopsis. This is in contrast to other plant species such as maize, 
petunia, or tomato, in which flavonoid deficiency leads to aberrant pollen tube growth, root 
hair growth, pavement cells, and stomata density (Mo et al., 1992; Liu-Gitz et al., 2000; 
Taylor and Grotewold, 2005; Schijlen et al., 2007). 
 
The rol1-2 phenotype is modified via auxin-dependent and –independent processes  
Auxin is a phytohormone involved in a plethora of plant developmental processes. 
Modifying auxin transport directly affects plant growth (Friml, 2003). The rol1-2 mutation 
causes an increase in auxin concentration in cotyledons, which induces hyponastic growth 
and a reduction in stomatal density. This conclusion is based on the finding that treatment 
of wild type plants with the auxin transport inhibitor NPA can at least partly mimic the 
rol1-2 mutant phenotype. A hyponastic growth phenotype is also found in the Arabidopsis 
mutants msg1 and cnr1 that are both impaired in their auxin response (Watahiki and 
Yamamoto, 1997; Laxmi et al., 2006). Although the influence of auxin on stomata 
distribution is known (Vandenbussche and Vanderstraaten, 2007), the stomatal density is 
much more affected in rol1-2 than in the NPA-treated wild type. This suggests that 
flavonols also play an auxin-independent role in the patterning of stomata. The tt4 
mutation, which blocks flavonoid biosynthesis (Shirley et al., 1995), neutralizes the effect 
of rol1-2 on auxin distribution and suppresses the rol1-2 cotyledon phenotype. Auxin 
transport has been shown to be negatively regulated by flavonols and is increased in tt4 
mutants when compared to wild type (Jacobs and Rubery, 1988; Brown et al., 2001; Buer 
and Muday, 2004; Peer et al., 2004). Recent experiments have shown that unglycosylated 
kaempferol and quercetin are particularly able to compete with the auxin transport 
inhibitor NPA for a high affinity-binding site found in a protein complex containing 
AtPGP1, AtPGP2, and AtMDR1/AtPGP19. Among these proteins a role in auxin transport 
for AtPGP1 and AtMDR1/AtPGP9 has been demonstrated (Noh et al., 2001; Murphy et 
al., 2002; Geisler et al., 2005; Multani et al., 2003). Flavonols are likely then to directly 
modulate auxin transport, a process that is reduced in the kaempferol over-accumulating 
mutant tt7 (Peer et al., 2004). It is possible, therefore, that the change in auxin 
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concentration observed in rol1-2 is caused by kaempferol-induced modulation of auxin 
transport. 
Our data indicate that the aberrant size of stomata, pavement cell shape, trichome 
formation, and part of the stomatal density phenotype in rol1-2 plants is not caused by 
modified auxin distribution, but rather flavonols play a role in auxin-independent cell 
growth and development. 
 
The observed mutant phenotypes are specific for rol1-2  
A number of flavonoid accumulation mutants have been described (Lepiniec et al., 2006). 
There are no reports of rol1-2 -like phenotypes for tt mutants, suggesting that the aberrant 
development of rol1-2 seedlings is induced by the modified flavonol glycosylation profile 
or the combination of aberrant cell-wall development (Diet et al., 2006) and the modified 
flavonol profile. K-G-3 and K-uk are the two flavonol glycosides whose accumulation in 
shoots correlates with the development of the rol1-2 phenotype. In lines developing a wild-
type shoot phenotype, they are present in very low amounts or not at all, respectively. 
While K-G-3 (kaempferol-3-O-glucose) has been identified in Arabidopsis, K-uk, might be 
kaempferol-3-O-(6’’-acetyl-glucoside) that has so far only been found in needles of 
Pinaceae species (Slimestad, 2003). Unfortunately, it is not possible to provide these 
flavonols exogenously since glycosylated flavonols are not taken up by the plant (Klein et 
al., 2000). It is not possible, therefore, to define these flavonols as the rol1-2 phenotype-
inducing compounds. It is possible that unglycosylated kaempferol, present in amounts 
below the detection limit, is the biologically active compound. The turnover-rate of K-G-3 
and K-uk might be different from other kaempferol glycosides, leading to abnormal levels 
of free aglycone kaempferol, which in turn affects plant development. 
The mechanism(s) by which the flavonol(s) modify cell growth remains to be elucidated. 
A number of processes can be influenced by flavonoids (Peer and Murphy, 2006). Here, 
we could show a change in shoot auxin concentration and provide evidence for an auxin-
independent mechanism. One interesting aspect is the function of flavonoids in ROS 
homeostasis (Peer and Murphy, 2006), since ROS are known to influence cell growth 
(Gapper and Dolan, 2006). In mammalian cell systems, flavonoids have been shown to 
interfere with actin (Peer and Murphy, 2006). This is of interest since mutations affecting 
the actin cytoskeleton in Arabidopsis and maize have been shown to result in aberrant 
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pavement cells (Frank et al., 2003; Mathur et al., 2003; Djakovic et al., 2006). Having 
established that flavonols can interfere with cell development it will be necessary to 
unravel the mechanisms by which they influence these processes. 
 
 
Methods 
Plant material and growth conditions 
The lrx1, rol1, tt4 (2YY6 allele), and ugt78D1 mutants are Columbia accessions and tt7 is a 
Landsberg erecta accession. These lines are described elsewhere (Shirley et al., 1995; 
Baumberger et al., 2001; Jones et al., 2003; Diet et al., 2006). The 2YY6 allele of tt4 
contains a max4 mutation which affects auxin-dependent processes (Bennett et al., 2006). 
Using a molecular marker (see below), MAX4 tt4 single mutants were selected in the F2 
generation of a back-cross with a Columbia plant. Molecular markers for all mutations (see 
below) were used to establish the different lines used in this study. For tt4 and tt7, the lack 
of anthocyanin staining in young seedlings and the yellow seed color were used as visual 
markers for selecting homozygous mutants, which were confirmed using molecular 
markers.  
For growth of plants in sterile conditions, seeds were surface sterilized with 1% sodium 
hypochlorite, 0.03% Triton X -100, stratified 3-4 days at 4°C, and grown for 5 days on 
half-strength MS-medium containing 0.6% Phytagel (Sigma), 2% sucrose, 100 mg/l myo-
inositol with a 16 h light / 8 h dark cycle at 22°C. For crosses and propagation of the 
plants, seedlings were transferred to soil and grown in growth chambers with a 16 h light / 
8 h dark cycle at 22°C. 
For the chemical complementation of the rol1-2 tt4 double mutant, seedlings were grown 
for 7 days on agar plates as described above, complemented with 30 µM naringenin, in a 
horizontal orientation. Since this amount of naringenin is not fully soluble in water, the 
exact final concentration in the agar-medium is not certain. 
Molecular markers for tt4, tt7, and max4 
Molecular markers for lrx1 and rol1-2 were previously described (Diet et al., 2004; 2006). 
The point mutations in tt4, tt7, and max4 were confirmed by amplification of genomic 
DNA, comparing mutants to the wild type DNA. Based on this information, CAPS 
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markers could be established for all mutations. For tt4 and max4, point mutations had to be 
introduced in one primer (underlined positions) to create a restriction site polymorphism. 
tt4: tt4_F CCAACAGTGAACACATGACCGAC and tt4_R GTTTCCGAATTGTCG 
ACTTAGCGC; digested with Eco 47III. 
tt7: tt7_F CAAACCCAACACTATGGCAACTC and tt7_R GTTTGAAATCTTCGAGA 
GCTTTAG; digested with Mse I. 
max4: max4_F GCGGGTGAGGTGTCGAAGTGGTACGT and max4_R 
AACCATCCATAAACTATGATCTAC; digested with Sna BI. 
Microscopy and root measurements 
Light microscopic observations were made using a Leica stereomicroscope MZ125. For 
measurements of root epidermal cells, pictures were taken of fully elongated root sections 
of 6-day-old seedlings by DIC microscopy using an axioplan microscope (Zeiss, Jena, 
Germany). Low temperature SEM was performed as described in Baumberger et al. 
(2001). 
Gel prints of epidermal cells were produced following an established protocol (Horiguchi 
et al., 2006), and observed by DICP microscopy using a Leica DMR microscope. 
For root length and cell length measurements, seedlings were grown in a vertical 
orientation for 5 days. For root length, 25 seedlings per line were used. For root hair, 
trichoblast, and atrichoblast measurements, at least 25 cells originating from at least 4 
different seedlings were used. 
GUS- and DABP-staining 
GUS staining was performed in 50 mM sodium phosphate pH 7.0, 10 mM EDTA, 0.5 mM 
K3Fe(CN)6, 0.5 mM K4Fe(CN)6, 0.1% Triton X-100, and 1 mM 5-bromo-4-chloro-3-
indolyl-β-D-glucuronic acid between 2 h and 16 h at 37°C. 
Flavonoids were visualized by the fluorescence of flavonoid-conjugated DPBA after 
excitation with blue light (Peer et al., 2001). Plants were grown for six days prior to 
staining. Fluorescent staining of whole seedlings was performed according to Buer and 
Muday (2004). Fluorescence was achieved by excitation with FITC filters (450 to 490 nm, 
suppression long pass 515 nm) on a Leica DMR fluorescence microscope and 10X or 20 X 
objectives. Digital images were captured with a Leica DC300 F charge coupled device 
(CCD) camera. 
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Flavonoid analysis and auxin measurement 
For the analysis of the flavonol accumulation profile, seedlings were grown in a vertical 
orientation for six days on half-strength MS as described above. One hundred intact 
seedlings were cut in the hypocotyl region and roots and shoots pooled separately, frozen 
in liquid nitrogen and lyophilized to determine the dry weight. The dried material was 
incubated in 500 µl 80% methanol overnight at 4°C and subsequently macerated with a 
pestle, followed by vigorous vortexing. After pelleting the cell debris by centrifugation, the 
supernatant was transferred to a fresh tube and evaporated in a speed-vac centrifuge, with 
the temperature being limited to a maximum of 43°C. After evaporation, the pellet was 
resuspended in 100 µl fresh 80% methanol and used for analysis. 
Flavonoid derivatives used as reference were commercially available (I-G-3, Q-G-3; 
Extrasynthese), or obtained from Dr. Veit (K-G-3, K-G-3-G-7, K-G-3-R-7, Q-R-G-3-R-7). 
The flavonoid profile analyses were performed by HPLC-MS on an Agilent 1100 HPLC 
system (Agilent Technologies) fitted with a HTS PAL autosampler (CTC Analytics), and 
an ESQUIRE-LC ion trap mass spectrometer (Bruker Daltonics). Chromatographic 
conditions: Nucleosil 100-3 C18 column (3 µm, 2 x 250 mm, Macherey-Nagel); flow rate 
0.170 mL min-1. Mobile phase: gradient within 25 min from 10 to 25% of solvent B, and 
then within 10 min from 25 to 70% of B (solvent A: 0.1% (v/v) HCOOH in H2O), solvent 
B: 0.1% (v/v) HCOOH in MeCN). MS conditions: Nebulizer gas (nitrogen) 40 psi, dry gas 
(nitrogen) 9 l/min, dry temperature 300°C, HV capillary 4000 V, HV EndPlate offset -500 
V, capillary exit -100 V, skimmer1 -28.9 V, and trap drive 53.4. The electrospray MS were 
acquired in the negative mode, at normal resolution (0.6 u at half peak height), under ion 
charge control conditions (ICC = 10'000) in the mass range from m/z 100 to 1000. MS/MS 
experiments were performed at 4u isolation width, the fragmentation cut-off set by "fast 
calc", and 0.9V fragmentation amplitude in the "SmartFrag" mode. 
For auxin measurement, 250 mg root or hypocotyl/cotyledon tissue was collected, frozen 
in liquid nitrogen, macerated, suspended in 100% methanol, briefly warmed to 70°C, and 
kept for 30 min with continuous gentle shaking. Prior to warming to 70°C, 100 pmol [2H]2-
IAA was added as the internal standard. After centrifugation, the pellet was dried to 
determine the dry weight and the supernatant was used for auxin quantification. The GC-
MS/MS analysis of IAA contents was carried out according to Müller et al. (2002). In 
brief, the samples were pre-cleaned by microscale solid-phase extraction on custom-made 
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cartridges containing a silica-based aminopropyl matrix. After application of the samples 
and washing the microcolumn with 250 µL CHCl3:2-propanol = 2:1 (v/v), the IAA fraction 
was eluted twice with 200 µL diethyl ether containing 2% acetic acid. Thereafter, the 
samples were dried, re-dissolved in 20 µL methanol, and treated with ethereal 
diazomethane. Subsequently samples were transferred to autosampler vials and excessive 
diazomethane and solvent was removed in a gentle stream of nitrogen. The methylated 
samples were then taken up in 10 µL of chloroform. Aliquots of 1 µL of each sample were 
injected into the GC-MS system for separation and mass fragment analysis using the 
autosampler and system quoted in the following. All spectra were recorded on a Varian 
Saturn 2000 ion-trap mass spectrometer connected to a Varian CP-3800 gas 
chromatograph equipped with a CombiPal autoinjector (Varian). 
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